{"content":"<li class=\"n-box-item date-title\" data-end=\"1521518399\" data-start=\"1521432000\" data-txt=\"Monday, December 23, 2019\">Monday, March 19, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3340320\" data-ts=\"1521500718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOG\" target=\"_blank\">NOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340320-northern-oil-and-gas-to-launch-105m-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northern Oil and Gas to launch $105M stock offering</a></h4><ul>     <li>Northern Oil and Gas (NYSEMKT:<a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a>) <font color='red'>-12.1%</font> after-hours as it announces a <a href=\"https://seekingalpha.com/pr/17106057-northern-oil-gas-inc-announces-public-offering-common-stock\" target=\"_blank\">public offering</a> of $105M of common shares, with an underwriters option to purchase up to an additional $15.75M in additional shares.</li>     <li>NOG says it plans to use the proceeds to continue to pursue acquisition opportunities, to fund its drilling program and for general corporate purposes other than debt repayment.</li>     <li>Separately, NOG says it expects Q1 average daily production to increase by 5%-6% Q/Q and <a href=\"https://seekingalpha.com/pr/17106074-northern-oil-gas-inc-provides-first-quarter-update-increases-2018-production-guidance\" target=\"_blank\">raises FY 2018 production guidance</a>, now seeing an 18%-22% Y/Y increase compared to prior guidance indicating a 16%-20% gain.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340320\" data-linked=\"Northern Oil and Gas to launch $105M stock offering\" data-tweet=\"$NOG - Northern Oil and Gas to launch $105M stock offering https://seekingalpha.com/news/3340320-northern-oil-and-gas-to-launch-105m-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3340320-northern-oil-and-gas-to-launch-105m-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340317\" data-ts=\"1521499458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340317-nyt-facebook-security-chief-exiting-company-amid-disagreements\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NYT: Facebook security chief exiting company amid disagreements</a></h4><ul>     <li>Amid escalating fallout from a data leak, Facebook's (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a>) chief information security officer, Alex Stamos, is <a href=\"https://www.nytimes.com/2018/03/19/technology/facebook-alex-stamos.html\" target=\"_blank\">leaving the company</a>, <i>The New York Times</i> reports.</li>     <li>After news broke of a leak of information via research firm Cambridge Analytica, Stamos spent his <a href=\"https://twitter.com/alexstamos\" target=\"_blank\">weekend on Twitter</a> pushing back on characterizing the incident as a \"breach,\" pointing out that data access is permitted and then that usage is limited by legal agreement.</li>     <li>According to the report, Stamos has clashed with other Facebook insiders, including COO Sheryl Sandberg, over transparency on Russian activity on the platform (Stamos reportedly pushed for investigating and disclosing more activity).</li>     <li>He decided to leave in December after his day-to-day responsibilities were reassigned, but was persuaded to stay through August because execs thought his departure would look bad, sources told the <i>NYT.</i></li>     <li>Share closed <font color='red'>down 6.8%</font> today; they're <font color='red'>down another 0.8%</font> after hours.</li>     <li><strong>Updated 7:34 p.m.:</strong> In a <a href=\"https://twitter.com/alexstamos/status/975875310896914433\" target=\"_blank\">Twitter response</a>, Stamos says \"Despite the rumors, I'm still fully engaged with my work at Facebook. It's true that my role did change. I'm currently spending more time exploring emerging security risks and working on election security.\"</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3340252-facebook-launches-audit-cambridge-determine-datas-fate-shares-minus-7_3-percent\" target=\"_blank\">Facebook launches audit of Cambridge to determine data's fate; shares -7.3%</a> (Mar. 19 2018)</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3340108-facebook-minus-3_33-percent-cambridge-analytica-fallout\" target=\"_blank\">Facebook -3.33% on Cambridge Analytica fallout</a> (Mar. 19 2018)</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3340051-facebook-suspends-trump-affiliated-data-firm-draws-uk-probe-updated\" target=\"_blank\">Facebook suspends Trump-affiliated data firm, draws UK probe (updated)</a> (Mar. 17 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340317\" data-linked=\"NYT: Facebook security chief exiting company amid disagreements\" data-tweet=\"$FB - NYT: Facebook security chief exiting company amid disagreements https://seekingalpha.com/news/3340317-nyt-facebook-security-chief-exiting-company-amid-disagreements?source=tweet\" data-url=\"https://seekingalpha.com/news/3340317-nyt-facebook-security-chief-exiting-company-amid-disagreements\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>89&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340315\" data-ts=\"1521497588\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TKR\" target=\"_blank\">TKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340315-timkenplus-6-after-raising-2018-earnings-sales-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Timken +6% after raising 2018 earnings, sales outlook</a></h4><ul>     <li>Timken (NYSE:<a href='https://seekingalpha.com/symbol/TKR' title='Timken Co.'>TKR</a>) <font color='green'>+6.2%</font> after-hours on news that it is <a href=\"https://seekingalpha.com/pr/17106138-timken-increases-outlook-2018\" target=\"_blank\">raising its earnings and sales outlook</a> for 2018, citing \"improved market strength and our continued outgrowth and operational excellence initiatives.\"</li>     <li>TKR says it now sees FY 2018 EPS of $3.50-$3.60 vs. its prior guidance of $3.20-$3.30 and the $3.30 analyst consensus estimate, on a 12%-13% increase in revenues to $3.36B-$3.39B vs. its previous guidance of 9%-10% sales growth and $3.31B consensus.</li>     <li>TKR forecasts 2018 Mobile Industries sales to rise 13%-14% in 2018 and Process Industries sales to increase by 11%-12%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340315\" data-linked=\"Timken +6% after raising 2018 earnings, sales outlook\" data-tweet=\"$TKR - Timken +6% after raising 2018 earnings, sales outlook https://seekingalpha.com/news/3340315-timkenplus-6-after-raising-2018-earnings-sales-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3340315-timkenplus-6-after-raising-2018-earnings-sales-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340308\" data-ts=\"1521495688\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNA\" target=\"_blank\">ARNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340308-after-hours-gainers-losers-3-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (3/19/2018)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/ARNA' title='Arena Pharmaceuticals, Inc.'>ARNA</a> <font color='green'>+24.6%</font>. <a href='https://seekingalpha.com/symbol/ELGX' title='Endologix Inc'>ELGX</a> <font color='green'>+8.1%</font>. <a href='https://seekingalpha.com/symbol/HLIT' title='Harmonic Inc.'>HLIT</a> <font color='green'>+6.4%</font>. <a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a> <font color='green'>+6.2%</font>. <a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a> <font color='green'>+6.1%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics'>PTI</a> <font color='red'>-7.3%</font>. <a href='https://seekingalpha.com/symbol/GLYC' title='GlycoMimetics'>GLYC</a>&nbsp;<font color='red'>-4.6%</font>. <a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a> <font color='red'>-3.6%</font>. <a href='https://seekingalpha.com/symbol/TVIX' title='VelocityShares Daily 2x VIX Short-Term ETN'>TVIX</a> <font color='red'>-2.8%</font>. <a href='https://seekingalpha.com/symbol/ADVM' title='Adverum Biotechnologies, Inc.'>ADVM</a> <font color='red'>-2.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340308\" data-linked=\"After Hours Gainers / Losers (3/19/2018)\" data-tweet=\"$ARNA $ARNA $ELGX - After Hours Gainers / Losers (3/19/2018) https://seekingalpha.com/news/3340308-after-hours-gainers-losers-3-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3340308-after-hours-gainers-losers-3-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340302\" data-ts=\"1521493572\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNJN\" target=\"_blank\">FNJN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340302-finjanplus-8_3-on-symantec-payment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finjan +8.3% on Symantec payment</a></h4><ul><li>        Finjan (NASDAQ:<a href='https://seekingalpha.com/symbol/FNJN' title='Finjan Holdings, Inc.'>FNJN</a>) <a href=\"https://seekingalpha.com/filing/3942466\" target=\"_blank\">announces</a> receiving the $65M payment from Symantec (NASDAQ:<a href='https://seekingalpha.com/symbol/SYMC' title='Symantec Corporation'>SYMC</a>) under the confidential patent license and settlement agreement.</li><li>               Finjan shares are&nbsp;<font color='green'>up 8.3%</font>&nbsp;aftermarket to $3.15.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3340302\" data-linked=\"Finjan +8.3% on Symantec payment\" data-tweet=\"$FNJN $FNJN $NLOK - Finjan +8.3% on Symantec payment https://seekingalpha.com/news/3340302-finjanplus-8_3-on-symantec-payment?source=tweet\" data-url=\"https://seekingalpha.com/news/3340302-finjanplus-8_3-on-symantec-payment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340283\" data-ts=\"1521491389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XNCR\" target=\"_blank\">XNCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340283-xencor-readies-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xencor readies stock offering</a></h4><ul><li>Xencor (NASDAQ:<a href='https://seekingalpha.com/symbol/XNCR' title='Xencor, Inc.'>XNCR</a>) <a href=\"https://seekingalpha.com/pr/17106044-xencor-inc-announces-proposed-public-offering-common-stock\" target=\"_blank\">initiates </a>a public offering of 5M shares of common stock. Price and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340283\" data-linked=\"Xencor readies stock offering\" data-tweet=\"$XNCR - Xencor readies stock offering https://seekingalpha.com/news/3340283-xencor-readies-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3340283-xencor-readies-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340281\" data-ts=\"1521491256\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORCL\" target=\"_blank\">ORCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340281-oracleminus-2_6-on-q3-in-line-revenue-32-cloud-revenue-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oracle -2.6% on Q3 in-line revenue, 32% cloud revenue growth</a></h4><ul><li>        Oracle (NYSE:<a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a>) shares<font color='red'> drop 2.6%</font>&nbsp;aftermarket following a Q3 report that bet on EPS but met on revenue with a 5.5% Y/Y growth.</li><li>               Revenue breakdown: Cloud and On-Premise Software, $8B (+8% Y/Y); Cloud Software as a Service, $1.2B (+33%); Cloud Platform as a Service plus Infrastructure as a Service, $415M (+28%); Total Cloud Revenues, $1.6B (+32%). &nbsp;&nbsp;</li><li>               Key metrics: Total operating expenses, $6.4B (-1%); cash and equivalents, $19.5B; total liabilities (current and non-current), $89.9B.&nbsp;</li><li>               Earnings call is scheduled for 5 PM ET with webcast available <a href=\"http://investor.oracle.com/overview/highlights/default.aspx\" target=\"_blank\">here</a>.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17106025-q3-fy18-cloud-revenues-32-percent-1_6-billion-total-revenues-6-percent-9_8-billion\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3340260-oracle-beats-0_11-revenue-line\" target=\"_blank\">Oracle beats by $0.11,  revenue in-line</a> (March 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340281\" data-linked=\"Oracle -2.6% on Q3 in-line revenue, 32% cloud revenue growth\" data-tweet=\"$ORCL - Oracle -2.6% on Q3 in-line revenue, 32% cloud revenue growth https://seekingalpha.com/news/3340281-oracleminus-2_6-on-q3-in-line-revenue-32-cloud-revenue-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3340281-oracleminus-2_6-on-q3-in-line-revenue-32-cloud-revenue-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340265\" data-ts=\"1521490259\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KLAC\" target=\"_blank\">KLAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340265-b-riley-kla-tencor-attractive-on-pullback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">B. Riley: KLA-Tencor attractive on pullback</a></h4><ul><li>           B. Riley calls KLA-Tencor (NASDAQ:<a href='https://seekingalpha.com/symbol/KLAC' title='KLA-Tencor Corporation'>KLAC</a>) shares attractive after the pullback today related to the Orbotech (ORBk) acquisition. </li><li> The firm says Orbotech has sound strategic logic and a reasonable cost synergies profile that will enhance KLA-Tencor&rsquo;s long-term revenue growth and EPS potential. </li><li> B. Riley thinks the pullback was due to a broad market decline rather than dissatisfaction with the transaction. </li><li> Firm says the deal could rekindle interest in small-cap semiconductor M&amp;A with potential movers Rudolph Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/RTEC' title='Rudolph Technologies, Inc.'>RTEC</a>) and Camtek (NASDAQ:<a href='https://seekingalpha.com/symbol/CAMT' title='Camtek Ltd.'>CAMT</a>). </li><li> Source: Briefing.com. </li><li> KLAC shares closed today&nbsp;<font color='red'>down 3.9%</font>&nbsp;to $115.98.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3340122-kla-tencor-acquires-orbotech-3_4b\" target=\"_blank\">KLA-Tencor acquires Orbotech for $3.4B</a> (March 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340265\" data-linked=\"B. Riley: KLA-Tencor attractive on pullback\" data-tweet=\"$KLAC $KLAC $RTEC - B. Riley: KLA-Tencor attractive on pullback https://seekingalpha.com/news/3340265-b-riley-kla-tencor-attractive-on-pullback?source=tweet\" data-url=\"https://seekingalpha.com/news/3340265-b-riley-kla-tencor-attractive-on-pullback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340266\" data-ts=\"1521490259\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTI\" target=\"_blank\">PTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340266-proteostasis-launches-9m-share-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Proteostasis launches 9M-share stock offering</a></h4><ul><li>Proteostasis Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics'>PTI</a>) <a href=\"https://seekingalpha.com/pr/17106023-proteostasis-therapeutics-announces-proposed-public-offering-common-stock\" target=\"_blank\">initiates </a>a public offering of 9M shares of common stock. Price and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340266\" data-linked=\"Proteostasis launches 9M-share stock offering\" data-tweet=\"$PTI - Proteostasis launches 9M-share stock offering https://seekingalpha.com/news/3340266-proteostasis-launches-9m-share-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3340266-proteostasis-launches-9m-share-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340264\" data-ts=\"1521490222\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340264-blackberryplus-5-on-enterprise-partnership-microsoft\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry +5% on enterprise partnership with Microsoft</a></h4><ul>     <li>BlackBerry (NYSE:<a href='https://seekingalpha.com/symbol/BB' title='BlackBerry Ltd.'>BB</a>) is jumping in postmarket, <font color='green'>up 5.1%</font>, on news of a <a href=\"https://seekingalpha.com/pr/17106005-blackberry-microsoft-partner-empower-mobile-workforce\" target=\"_blank\">strategic partnership</a> with Microsoft (NASDAQ:<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a>) on enterprise software.</li>     <li>The two have a first-of-its-kind solution, BlackBerry Enterprise BRIDGE -- a way for the two companies' joint customers to use native Microsoft mobile apps within BlackBerry Dynamics, they say.</li>     <li>The partnership looks to combine cloud and productivity products from Microsoft with BlackBerry's strength in mobility and security.</li>   <li>BlackBerry also announced a <a href=\"https://seekingalpha.com/pr/17106008-blackberry-furthers-leadership-securing-enterprise-things\" target=\"_blank\">new wave of capabilities</a> aimed at the \"Enterprise of Things,\" with new do-not-disturb features on BlackBerry Work; more privacy features in BlackBerry WorkLife; and increased sharing on persistent group chats in BlackBerry Connect, along with deployment simplification and security enhancements for developers.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3340264\" data-linked=\"BlackBerry +5% on enterprise partnership with Microsoft\" data-tweet=\"$BB $BB $MSFT - BlackBerry +5% on enterprise partnership with Microsoft https://seekingalpha.com/news/3340264-blackberryplus-5-on-enterprise-partnership-microsoft?source=tweet\" data-url=\"https://seekingalpha.com/news/3340264-blackberryplus-5-on-enterprise-partnership-microsoft\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>151&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340262\" data-ts=\"1521490120\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLYC\" target=\"_blank\">GLYC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340262-glycomimetics-readies-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GlycoMimetics readies equity offering</a></h4><ul><li>GlycoMimetics (NASDAQ:<a href='https://seekingalpha.com/symbol/GLYC' title='GlycoMimetics'>GLYC</a>) <a href=\"https://seekingalpha.com/pr/17106011-glycomimetics-announces-proposed-public-offering-common-stock\" target=\"_blank\">initiates </a>a public offering of 4.5M shares of common stock. Price and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340262\" data-linked=\"GlycoMimetics readies equity offering\" data-tweet=\"$GLYC - GlycoMimetics readies equity offering https://seekingalpha.com/news/3340262-glycomimetics-readies-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3340262-glycomimetics-readies-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340258\" data-ts=\"1521489775\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNA\" target=\"_blank\">ARNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340258-arena-pharmaceuticals-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arena Pharmaceuticals halted pending news</a></h4><ul><li>Nasdaq has <a href=\"http://www.nasdaqtrader.com/trader.aspx?id=tradehalts\" target=\"_blank\">suspended trading</a> in Arena Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ARNA' title='Arena Pharmaceuticals, Inc.'>ARNA</a>) pending the release of news.</li><li>The most likely event is Phase 2 data on ralinepag in ulcerative colitis.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340258\" data-linked=\"Arena Pharmaceuticals halted pending news\" data-tweet=\"$ARNA - Arena Pharmaceuticals halted pending news https://seekingalpha.com/news/3340258-arena-pharmaceuticals-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3340258-arena-pharmaceuticals-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340256\" data-ts=\"1521489516\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRP\" target=\"_blank\">TRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340256-transcanada-lower-tc-pipelines-higher-after-downplaying-ferc-impact\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TransCanada lower, TC Pipelines higher after downplaying FERC impact</a></h4><ul>     <li>TransCanada (<a href='https://seekingalpha.com/symbol/TRP' title='TransCanada Corporation'>TRP</a> <font color='red'>-1.8%</font>) is lower despite saying it <a href=\"https://seekingalpha.com/pr/17105170-transcanada-expects-material-financial-impact-proposed-tax-actions-federal-energy-regulatory\" target=\"_blank\">expects \"no material financial impact</a>\" from proposed <a href=\"https://seekingalpha.com/news/3339594-mlps-suffer-sharp-losses-ferc-nixes-income-tax-allowance-cost-recovery\" target=\"_blank\">tax policy changes</a> by the FERC, but its TC&nbsp;Pipelines (<a href='https://seekingalpha.com/symbol/TCP' title='TC PipeLines, LP'>TCP</a> <font color='green'>+3.6%</font>) MLP is higher after making a <a href=\"https://seekingalpha.com/pr/17105149-tc-pipelines-lp-provides-initial-response-ferc-orders\" target=\"_blank\">similar statement</a>.</li>     <li>TRP says ~50% of its U.S. natural gas pipeline 2018 revenues are derived from negotiated or discounted tariffs and would not be materially impacted by FERC's actions; TRP expects the percentage to increase to 65% in 2019 as growth projects are placed into service.</li>     <li>TCP, which owns part of TRP's U.S. pipeline network, says roughly half of its network receives negotiated service tolls, which are not subject to the agency ruling barring MLPs from recovering income taxes with their rate-making formulas.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340256\" data-linked=\"TransCanada lower, TC Pipelines higher after downplaying FERC impact\" data-tweet=\"$TRP $TRP $TCP - TransCanada lower, TC Pipelines higher after downplaying FERC impact https://seekingalpha.com/news/3340256-transcanada-lower-tc-pipelines-higher-after-downplaying-ferc-impact?source=tweet\" data-url=\"https://seekingalpha.com/news/3340256-transcanada-lower-tc-pipelines-higher-after-downplaying-ferc-impact\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>122&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340255\" data-ts=\"1521488119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSY\" target=\"_blank\">INSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340255-drug-stocks-in-red-on-trump-mulls-suing-pharma-firms-over-opioid-crisis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Drug stocks in the red on as Trump mulls suing pharma firms over opioid crisis</a></h4><ul><li>The market's down day notwithstanding, drug makers who have even a limited exposure to opioids are under pressure after President Trump <a href=\"https://www.cnbc.com/2018/03/19/drug-stocks-dive-as-trump-says-hes-considering-suing-drug-companies-over-opioid-crisis.html?__source=twitter%7Cmain\" target=\"_blank\">commented </a>that he is \"considering\" suing said firms over their role in the crisis. He made the comments during a speech in New Hampshire.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a> <font color='red'>-0.5%</font>)(<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt PLC'>MNK</a> <font color='red'>-5.7%</font>)(<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color='red'>-4.7%</font>)(DEPO <font color='red'>-5%</font>)(<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='red'>-2.6%</font>)(<a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a> <font color='red'>-2.4%</font>)(<a href='https://seekingalpha.com/symbol/ABC' title='AmerisourceBergen Corporation'>ABC</a> <font color='red'>-3.9%</font>)(<a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a> <font color='red'>-2.8%</font>)(<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color='red'>-3%</font>)(<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color='red'>-1.6%</font>)(<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color='red'>-2.2%</font>)(<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company'>PRGO</a> <font color='red'>-2.9%</font>)(<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color='red'>-2%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340255\" data-linked=\"Drug stocks in the red on as Trump mulls suing pharma firms over opioid crisis\" data-tweet=\"$INSY $INSYQ $MNK - Drug stocks in the red on as Trump mulls suing pharma firms over opioid crisis https://seekingalpha.com/news/3340255-drug-stocks-in-red-on-trump-mulls-suing-pharma-firms-over-opioid-crisis?source=tweet\" data-url=\"https://seekingalpha.com/news/3340255-drug-stocks-in-red-on-trump-mulls-suing-pharma-firms-over-opioid-crisis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>146&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340254\" data-ts=\"1521487758\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/D\" target=\"_blank\">D</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340254-dominion-energy-reaffirms-earnings-guidance-after-ferc-policy-change\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dominion Energy reaffirms earnings guidance after FERC policy change</a></h4><ul>     <li>Dominion Energy (<a href='https://seekingalpha.com/symbol/D' title='Dominion Energy, Inc.'>D</a> <font color='red'>-2.5%</font>) extends its recent losses deeper into 52-week lows despite <a href=\"https://seekingalpha.com/pr/17105638-dominion-energy-affirms-earnings-guidance-credit-objectives\" target=\"_blank\">reiterating guidance</a> for operating EPS of $0.95-$1.15 for Q1 and $3.80-$4.25 for FY 2018, as well as its 2017-20 compound earnings growth rate of 6%-8%.</li>     <li>The company says <a href=\"https://seekingalpha.com/news/3339594-mlps-suffer-sharp-losses-ferc-nixes-income-tax-allowance-cost-recovery\" target=\"_blank\">FERC's change in its tax allowance policy</a> that potentially lowers tax benefits&nbsp; \"will take years to  implement and, even then, will only impact revenues on a prospective  basis from the conclusion of any ratemaking process.\"</li>     <li>Dominion Energy Midstream Partners (<a href='https://seekingalpha.com/symbol/DM' title='Dominion Midstream Partners LP'>DM</a> <font color='red'>-17.8%</font>) says it does not anticipate any  revenue&nbsp;reductions during 2018-20 due to FERC's actions  and&nbsp;is still evaluating any long term impacts and their timing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340254\" data-linked=\"Dominion Energy reaffirms earnings guidance after FERC policy change\" data-tweet=\"$D $D $DM - Dominion Energy reaffirms earnings guidance after FERC policy change https://seekingalpha.com/news/3340254-dominion-energy-reaffirms-earnings-guidance-after-ferc-policy-change?source=tweet\" data-url=\"https://seekingalpha.com/news/3340254-dominion-energy-reaffirms-earnings-guidance-after-ferc-policy-change\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340252\" data-ts=\"1521486778\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340252-facebook-launches-audit-of-cambridge-to-determine-datas-fate-sharesminus-7_3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook launches audit of Cambridge to determine data&#39;s fate; shares -7.3%</a></h4><ul>   <li>Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color='red'>-7.3%</font>) -- its market cap pummeled by nearly $40B after <a href=\"https://seekingalpha.com/news/3340051-facebook-suspends-trump-affiliated-data-firm-draws-uk-probe-updated\" target=\"_blank\">revelations of data misuse</a> by Cambridge Analytica -- has hired a firm to <a href=\"https://newsroom.fb.com/news/2018/03/forensic-audits-cambridge-analytica/\" target=\"_blank\">conduct a \"comprehensive audit\"</a> of the research firm, as well as two individuals who don't work at Cambridge Analytica, including the creator of a personality-profile app that harvested user data.</li>    <li>Digital forensics firm Stroz Friedberg will do the audit on Facebook's behalf, and Cambridge Analytica has agreed to allow complete access to servers and systems.</li>    <li>Of the two individuals, app creator Aleksandr Kogan gave verbal agreement to submit to an audit, Facebook says, while Christopher Wylie has declined so far.</li>    <li>The goal of the audit is to determine whether the data still exists, though it was to be destroyed (and the parties certified had been destroyed).</li>    <li>Oppenheimer, meanwhile, is reiterating its Outperform rating, saying the decline presents a buying opportunity. Analyst Jason Helfstein has a price target of $225, now implying 31% upside from today's depressed price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340252\" data-linked=\"Facebook launches audit of Cambridge to determine data&#39;s fate; shares -7.3%\" data-tweet=\"$FB - Facebook launches audit of Cambridge to determine data&#39;s fate; shares -7.3% https://seekingalpha.com/news/3340252-facebook-launches-audit-of-cambridge-to-determine-datas-fate-sharesminus-7_3?source=tweet\" data-url=\"https://seekingalpha.com/news/3340252-facebook-launches-audit-of-cambridge-to-determine-datas-fate-sharesminus-7_3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>69&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340248\" data-ts=\"1521485226\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALO\" target=\"_blank\">ALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340248-alio-gold-to-buy-rye-patch-gold-in-c-128m-all-stock-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alio Gold to buy Rye Patch Gold in C$128M all-stock deal</a></h4><ul>     <li>Alio Gold (<a href='https://seekingalpha.com/symbol/ALO' title='Alio Gold Inc'>ALO</a> <font color='red'>-9.5%</font>) <a href=\"https://seekingalpha.com/pr/17105162-alio-gold-rye-patch-gold-announce-business-combination\" target=\"_blank\">agrees to acquire</a> Nevada-based producer Rye Patch Gold in an all-stock offer valued at ~C$128M.</li><li>Rye Patch's flagship Florida Canyon Mine produced 10,470 oz. of gold and 5,447 oz. silver in Q4 2017, and the proposed deal would lift Alio's pro forma output this year by 65% to 165K oz. of gold from two open-pit, heap leach operations.</li><li>At the conclusion of the deal, Alio Gold and Rye Patch  shareholders would own a respective 53% and 47% of the combined company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340248\" data-linked=\"Alio Gold to buy Rye Patch Gold in C$128M all-stock deal\" data-tweet=\"$ALO - Alio Gold to buy Rye Patch Gold in C$128M all-stock deal https://seekingalpha.com/news/3340248-alio-gold-to-buy-rye-patch-gold-in-c-128m-all-stock-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3340248-alio-gold-to-buy-rye-patch-gold-in-c-128m-all-stock-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340245\" data-ts=\"1521484262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPTT\" target=\"_blank\">OPTT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340245-ocean-power-tech-signs-deal-to-supply-powerbuoy-for-eni-demonstration\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocean Power Tech signs deal to supply PowerBuoy for Eni demonstration</a></h4><ul>     <li>Ocean Power Technologies (<a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a> <font color='green'>+3.3%</font>) is higher following an agreement with Eni (<a href='https://seekingalpha.com/symbol/E' title='ENI S.p.A.'>E</a> <font color='red'>-1%</font>) to provide its PB3 PowerBuoy for a <a href=\"https://seekingalpha.com/pr/17105444-ocean-power-technologies-signs-agreement-eni-s-p-provide-pb3-powerbuoy-subsea-oil-gas\" target=\"_blank\">demonstration</a> of one of Eni&rsquo;s subsea oil and gas operations, in OPTT's first commercial agreement in the oil and gas market</li>     <li>OPTT says the deal provides for a minimum two-year contract that includes an 18-month PB3 PowerBuoy  lease and associated project management, and the company will provide deployment support, remote data collection and monitoring.</li>     <li>The PowerBuoy will be deployed in the Adriatic Sea to advance Eni&rsquo;s Clean Sea technology for marine environmental monitoring and offshore asset inspection using autonomous underwater vehicles.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340245\" data-linked=\"Ocean Power Tech signs deal to supply PowerBuoy for Eni demonstration\" data-tweet=\"$OPTT $OPTT $E - Ocean Power Tech signs deal to supply PowerBuoy for Eni demonstration https://seekingalpha.com/news/3340245-ocean-power-tech-signs-deal-to-supply-powerbuoy-for-eni-demonstration?source=tweet\" data-url=\"https://seekingalpha.com/news/3340245-ocean-power-tech-signs-deal-to-supply-powerbuoy-for-eni-demonstration\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340241\" data-ts=\"1521483121\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DIS\" target=\"_blank\">DIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340241-black-panther-bests-tomb-raider-tops-600m-domestic-grosses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&#39;Black Panther&#39; bests &#39;Tomb Raider,&#39; tops $600M domestic grosses</a></h4><ul>   <li><i>Black Panther</i> (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color='red'>-1.3%</font>) held its box-office lead for a fifth week, holding off a charge from <i>Tomb Raider,</i> and became just the seventh film ever to gross $600M domestically.</li>    <li>The Marvel film drew $27M in grosses to top $23.5M from <i>Tomb Raider</i> (<a href=\"http://seekingalpha.com/symbol/TWX\" target=\"_blank\">TWX</a> <font color='red'>-1.5%</font>). Meanwhile, <i>A Wrinkle in Time</i> (NYSE:<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>) slipped to fourth with $16.6M, passed by a surprising $17.1M debut from faith-based drama <i>I Can Only Imagine</i> (<a href='https://seekingalpha.com/symbol/LGF.A' title='Lions Gate Entertainment Corp.'>LGF.A</a> <font color='red'>-2.7%</font>, <a href='https://seekingalpha.com/symbol/LGF.B' title='Lions Gate Entertainment Corp.'>LGF.B</a> <font color='red'>-2.3%</font>).</li>    <li>Another new film, <i>Love, Simon</i> (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='red'>-1.4%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='red'>-1.6%</font>), settled into the No. 5 spot with $11.5M.</li>    <li><i>Black Panther</i> is now just $18M domestically behind <i>The Avengers</i> in the rank of top Marvel Cinematic Universe films. Along with $605.4M domestically, it has $577.1M in international grosses; that makes it the 14th-biggest film of all time on a worldwide basis.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340241\" data-linked=\"&#39;Black Panther&#39; bests &#39;Tomb Raider,&#39; tops $600M domestic grosses\" data-tweet=\"$DIS $DIS $LGF.A - &#39;Black Panther&#39; bests &#39;Tomb Raider,&#39; tops $600M domestic grosses https://seekingalpha.com/news/3340241-black-panther-bests-tomb-raider-tops-600m-domestic-grosses?source=tweet\" data-url=\"https://seekingalpha.com/news/3340241-black-panther-bests-tomb-raider-tops-600m-domestic-grosses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340239\" data-ts=\"1521482464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KLDX\" target=\"_blank\">KLDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340239-energy-materials-top-gainers-losers-of-2-00-pm-3-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm (3/19/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KLDX' title='Klondex Mines Ltd.'>KLDX</a> <font color='green'>+54%</font>. <a href='https://seekingalpha.com/symbol/RKDA' title='Arcadia Biosciences'>RKDA</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/NG' title='NovaGold Resources, Inc'>NG</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/SDPI' title='Superior Drilling Products, Inc.'>SDPI</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/DM' title='Dominion Midstream Partners LP'>DM</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/HL' title='Hecla Mining Co.'>HL</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CLMT' title='Calumet Specialty Products Partners, L.P.'>CLMT</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/IO' title='ION Geophysical Corporation'>IO</a> <font color='red'>-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340239\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm (3/19/2018)\" data-tweet=\"$KLDX $KLDX $RKDA - Energy/Materials - Top Gainers / Losers as of 2:00 pm (3/19/2018) https://seekingalpha.com/news/3340239-energy-materials-top-gainers-losers-of-2-00-pm-3-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3340239-energy-materials-top-gainers-losers-of-2-00-pm-3-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340238\" data-ts=\"1521482125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCD\" target=\"_blank\">MCD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340238-reuters-mcdonalds-will-settle-labor-dispute\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: McDonald&#39;s will settle labor dispute</a></h4><ul><li>        A <a href=\"https://www.reuters.com/article/us-mcdonalds-nlrb-settlement/mcdonalds-proposes-settlement-in-u-s-labor-board-case-source-idUSKBN1GV2BL\" target=\"_blank\">Reuters source</a> says McDonald&rsquo;s (NYSE:<a href='https://seekingalpha.com/symbol/MCD' title='McDonald&#39;s Corporation'>MCD</a>) has agreed to settle a case on whether its accountable for franchisee labor law violations. Settlement terms were undisclosed.</li><li>               A National Labor Relations Board judge would need to approve the settlement. If approved, McDonald&rsquo;s could avoid a &ldquo;joint employer&rdquo; ruling that would make it liable for franchisee labor violations.&nbsp;</li><li>               McDonald&rsquo;s shares are&nbsp;<font color='red'>down 2%</font>&nbsp;to $159.20.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3340238\" data-linked=\"Reuters: McDonald&#39;s will settle labor dispute\" data-tweet=\"$MCD - Reuters: McDonald&#39;s will settle labor dispute https://seekingalpha.com/news/3340238-reuters-mcdonalds-will-settle-labor-dispute?source=tweet\" data-url=\"https://seekingalpha.com/news/3340238-reuters-mcdonalds-will-settle-labor-dispute\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340233\" data-ts=\"1521481766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAC\" target=\"_blank\">BAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340233-sec-gives-biggest-ever-whistleblower-award-for-bofa-settlement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SEC gives biggest-ever whistleblower award for BofA settlement</a></h4><ul><li>The SEC awarded <a href=\"https://www.wsj.com/articles/whistleblowers-helped-sec-bring-415-million-settlement-against-bank-of-america-1521479445\" target=\"_blank\">$83M to three whistleblowers</a> who aided in the $415M settlement with Bank of America (<a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color='red'>-0.8%</font>).</li><li>&ldquo;These courageous executives are a shining example for other people on Wall Street with integrity and are likely to lead to an increase in corporate whistleblowing,&rdquo; said Jordan Thomas, a lawyer who advises whistleblowers.</li><li>The 2016 case against BofA was regarding putting billions in customer assets at risk through misuse of cash and securities over a six-year period, to which the bank admitted wrongdoing.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340233\" data-linked=\"SEC gives biggest-ever whistleblower award for BofA settlement\" data-tweet=\"$BAC - SEC gives biggest-ever whistleblower award for BofA settlement https://seekingalpha.com/news/3340233-sec-gives-biggest-ever-whistleblower-award-for-bofa-settlement?source=tweet\" data-url=\"https://seekingalpha.com/news/3340233-sec-gives-biggest-ever-whistleblower-award-for-bofa-settlement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340230\" data-ts=\"1521480748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DBX\" target=\"_blank\">DBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340230-reuters-dropbox-ipo-oversubscribed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Dropbox IPO oversubscribed</a></h4><ul><li>        <a href=\"https://www.reuters.com/article/us-dropbox-ipo/dropbox-ipo-oversubscribed-sources-idUSKBN1GV2A7\" target=\"_blank\">Reuters sources</a> say Dropbox&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/DBX' title='Dropbox'>DBX</a>) IPO was oversubscribed, which could increase the 36M shares for sale by 5.4M if the underwriters buy more.&nbsp;</li><li>               The added interest could push the listing price ahead of its current range of $16 to $18 per share. At the high end, the IPO could raise nearly $650M at about a $7B valuation.&nbsp;</li><li>               The offering is expected to price Thursday and start listing the next day.&nbsp;</li><li>               Shares of competitor Box (NYSE:<a href='https://seekingalpha.com/symbol/BOX' title='Box'>BOX</a>) are&nbsp;<font color='red'>down 2.3%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3338241-dropbox-ipo-8b-valuation-private-placement-salesforce\" target=\"_blank\">Dropbox IPO: Up to $8B valuation, private placement by Salesforce</a> (March 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340230\" data-linked=\"Reuters: Dropbox IPO oversubscribed\" data-tweet=\"$DBX $DBX $BOX - Reuters: Dropbox IPO oversubscribed https://seekingalpha.com/news/3340230-reuters-dropbox-ipo-oversubscribed?source=tweet\" data-url=\"https://seekingalpha.com/news/3340230-reuters-dropbox-ipo-oversubscribed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340229\" data-ts=\"1521480659\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHTR\" target=\"_blank\">CHTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340229-charter-hires-bowman-to-new-position-leading-mobile-service-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Charter hires Bowman to new position leading mobile service offering</a></h4><ul>   <li>Charter Communications (<a href=\"http://seekingalpha.com/symbol/CHTR\" target=\"_blank\">CHTR</a> <font color='red'>-2.8%</font>) has established the <a href=\"https://seekingalpha.com/pr/17105882-charter-names-danny-bowman-chief-mobile-officer\" target=\"_blank\">role of chief mobile officer</a>, and named Danny Bowman to the position.</li>    <li>Bowman will lead the company's upcoming mobile service.</li>    <li>He's spent 25 years in mobile communications, with executive experience at Samsung, Sprint, Nextel, Cellular One and most recently LeEco North America, where he was chief revenue officer.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340229\" data-linked=\"Charter hires Bowman to new position leading mobile service offering\" data-tweet=\"$CHTR - Charter hires Bowman to new position leading mobile service offering https://seekingalpha.com/news/3340229-charter-hires-bowman-to-new-position-leading-mobile-service-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3340229-charter-hires-bowman-to-new-position-leading-mobile-service-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340321\" data-ts=\"1521479503\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HGT-OLD\" target=\"_blank\">HGT-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340321-hugoton-royalty-trust-to-pay-no-march-cash-distribution\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hugoton Royalty Trust to pay no March cash distribution</a></h4><ul>     <li>Hugoton Realty Trust (<a href='https://seekingalpha.com/symbol/HGT-OLD' title='Hugoton Royalty Trust'>HGT-OLD</a> <font color='red'>-16.6%</font>) plunges as much as 28% to a worst-ever $0.55/share after the oil and gas producer says it <a href=\"https://seekingalpha.com/pr/17105101-hugoton-royalty-trust-declares-march-cash-distribution-anticipated-increase-development\" target=\"_blank\">will not pay a March cash distribution</a>.</li>     <li>XTO Energy expects to spend $30M-$35M on property development costs this year, primarily on the projected drilling of four horizontal wells in Major County, Okla., during H2 2018, and it is raising its budgeted development deduction to $2.2M from the current $280K.</li>     <li>In light of the higher development costs, HGT will hold in reserve $414K that would have been distributed for March.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340321\" data-linked=\"Hugoton Royalty Trust to pay no March cash distribution\" data-tweet=\"$HGT-OLD - Hugoton Royalty Trust to pay no March cash distribution https://seekingalpha.com/news/3340321-hugoton-royalty-trust-to-pay-no-march-cash-distribution?source=tweet\" data-url=\"https://seekingalpha.com/news/3340321-hugoton-royalty-trust-to-pay-no-march-cash-distribution\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340220\" data-ts=\"1521478794\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRIO\" target=\"_blank\">DRIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340220-dariohealth-restates-three-quarterly-reports-due-to-changes-in-liability-warrants\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DarioHealth restates three quarterly reports due to changes in liability warrants</a></h4><ul><li>DarioHealth (<a href='https://seekingalpha.com/symbol/DRIO' title='DarioHealth Corp.'>DRIO</a> <font color='green'>+6%</font>)<a href=\"https://www.sec.gov/Archives/edgar/data/1533998/000114420418015400/tv488637_8k.htm\" target=\"_blank\"> has filed</a> amended 10-Qs for the periods ended March 30, 2017, June 30, 2017 and September 30, 2017 due to the re-measurement of certain liability warrants before their reclassification from liability to equity in Q1.</li><li>The impact was an increase in net loss in the prior periods but shareholders' equity was not affected.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340220\" data-linked=\"DarioHealth restates three quarterly reports due to changes in liability warrants\" data-tweet=\"$DRIO - DarioHealth restates three quarterly reports due to changes in liability warrants https://seekingalpha.com/news/3340220-dariohealth-restates-three-quarterly-reports-due-to-changes-in-liability-warrants?source=tweet\" data-url=\"https://seekingalpha.com/news/3340220-dariohealth-restates-three-quarterly-reports-due-to-changes-in-liability-warrants\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340218\" data-ts=\"1521478068\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340218-nasdaq-slides-2-facebook-tumbles-and-fed-gets-set-to-hike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nasdaq slides 2% as Facebook tumbles and Fed gets set to hike</a></h4><ul><li>Facebook is&nbsp;<font color='red'>down more than 7%</font>&nbsp;on renewed <a href=\"https://seekingalpha.com/news/3340108-facebook-minus-3_33-percent-cambridge-analytica-fallout\" target=\"_blank\">questions about the use</a> of customer data. It's helping the Nasdaq (NASDAQ:<a href='https://seekingalpha.com/symbol/QQQ' title='PowerShares QQQ Trust ETF'>QQQ</a>) to a&nbsp;<font color='red'>2.2% loss</font>&nbsp;at midday.</li><li>Meanwhile, the FOMC meets midweek and is fully expected to lift the Fed Funds rate by another 25 basis points. Markets will also be treated to a post-meeting press conference with new Fed boss Jay Powell. The S&amp;P 500 (NYSEARCA:<a href='https://seekingalpha.com/symbol/SPY' title='SPDR S&P 500 Trust ETF'>SPY</a>) is&nbsp;<font color='red'>down 1.5%</font>&nbsp;and Dow (NYSEARCA:<a href='https://seekingalpha.com/symbol/DIA' title='SPDR Dow Jones Industrial Average ETF'>DIA</a>)&nbsp;<font color='red'>1.3%</font>.</li><li>Fixed-income, thus far, isn't seeing much benefit from the selloff, with the 10-year Treasury yield flat at 2.83%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a> flat.</li><li>Seeing great benefit, though, is the VIX with a&nbsp;<font color='green'>26% gain</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a>, <a href='https://seekingalpha.com/symbol/UVXY' title='ProShares Ultra VIX Short-Term Futures ETF'>UVXY</a>, <a href='https://seekingalpha.com/symbol/XIV' title='VelocityShares Daily Inverse VIX Short-Term ETN'>XIV</a>, <a href='https://seekingalpha.com/symbol/TVIX' title='VelocityShares Daily 2x VIX Short-Term ETN'>TVIX</a>, <a href='https://seekingalpha.com/symbol/SVXY' title='ProShares Short VIX Short-Term Futures ETF'>SVXY</a>, <a href='https://seekingalpha.com/symbol/VIXY' title='ProShares VIX Short-Term Futures ETF'>VIXY</a>, <a href='https://seekingalpha.com/symbol/ZIV' title='VelocityShares Daily Inverse VIX Medium-Term ETN'>ZIV</a>, <a href='https://seekingalpha.com/symbol/VXZ' title='iPath S&P 500 VIX Mid-Term Futures ETN'>VXZ</a>, <a href='https://seekingalpha.com/symbol/VIXM' title='ProShares VIX Mid-Term Futures ETF'>VIXM</a>, <a href='https://seekingalpha.com/symbol/VMAX' title='REX VolMAXX Long VIX Weekly Futures Strategy ETF'>VMAX</a>, <a href='https://seekingalpha.com/symbol/VMIN' title='REX VolMAXX Inverse VIX Weekly Futures Strategy ETF'>VMIN</a>, <a href='https://seekingalpha.com/symbol/VIIX' title='VelocityShares VIX Short-Term ETN'>VIIX</a>, <a href='https://seekingalpha.com/symbol/CVOL' title='C-Tracks ETN on CVOL'>CVOL</a>, <a href='https://seekingalpha.com/symbol/XVZ' title='iPath S&P 500 Dynamic VIX ETN'>XVZ</a>, <a href='https://seekingalpha.com/symbol/TVIZ' title='VelocityShares Daily 2x VIX Medium-Term ETN'>TVIZ</a>, <a href='https://seekingalpha.com/symbol/XXV' title='iPath Inverse S&P 500 VIX Short-Term Futures ETN'>XXV</a>, <a href='https://seekingalpha.com/symbol/IVOP' title='iPath Inverse S&P 500 VIX Short-Term Futures ETN'>IVOP</a>, <a href='https://seekingalpha.com/symbol/VIIZ' title='VelocityShares VIX Medium-Term ETN'>VIIZ</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3340218\" data-linked=\"Nasdaq slides 2% as Facebook tumbles and Fed gets set to hike\" data-tweet=\"$QQQ $SPY $DIA - Nasdaq slides 2% as Facebook tumbles and Fed gets set to hike https://seekingalpha.com/news/3340218-nasdaq-slides-2-facebook-tumbles-and-fed-gets-set-to-hike?source=tweet\" data-url=\"https://seekingalpha.com/news/3340218-nasdaq-slides-2-facebook-tumbles-and-fed-gets-set-to-hike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>92&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340217\" data-ts=\"1521477948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFEC\" target=\"_blank\">NFEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340217-midday-gainers-losers-3-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (3/19/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NFEC' title='NF Energy Saving Corp.'>NFEC</a> <font color='green'>+177%</font>. <a href='https://seekingalpha.com/symbol/KLDX' title='Klondex Mines Ltd.'>KLDX</a> <font color='green'>+53%</font>. <a href='https://seekingalpha.com/symbol/HRTX' title='Heron Therapeutics, Inc.'>HRTX</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/GERN' title='Geron Corporation'>GERN</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/XRM' title='Xerium Technologies, Inc.'>XRM</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/PAR' title='PAR Technology Corporation'>PAR</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/SGOC' title='SGOCO Techn'>SGOC</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/XTNT' title='Xtant Medical Holdings, Inc.'>XTNT</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/REDU' title='RISE Education Cayman Ltd'>REDU</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MFGP' title='Micro Focus International plc ADR'>MFGP</a> <font color='red'>-46%</font>. <a href='https://seekingalpha.com/symbol/FAC' title='First Acceptance Corporation'>FAC</a> <font color='red'>-27%</font>. <a href='https://seekingalpha.com/symbol/CDTX' title='Cidara Therapeutics'>CDTX</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a> <font color='red'>-19%</font>. RXII <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/ANY' title='Sphere 3D Corp.'>ANY</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/FLKS' title='Flex Pharma'>FLKS</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/SEED' title='Origin Agritech Limited'>SEED</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/OLED' title='Universal Display Corporation'>OLED</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/ZS' title='Zscaler'>ZS</a> <font color='red'>-14%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340217\" data-linked=\"Midday Gainers / Losers (3/19/2018)\" data-tweet=\"$NFEC $BIMI $KLDX - Midday Gainers / Losers (3/19/2018) https://seekingalpha.com/news/3340217-midday-gainers-losers-3-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3340217-midday-gainers-losers-3-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340216\" data-ts=\"1521477905\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYPT\" target=\"_blank\">EYPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340216-fda-accepts-psividas-marketing-application-for-durasert-for-psu-action-date-november-5-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA accepts pSivida&#39;s marketing application for Durasert for PSU, action date November 5; shares ahead 5%</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17105861-psivida-announces-fda-acceptance-filing-new-drug-application-nda-durasert-three-year\" target=\"_blank\">accepts for review</a> pSivida's (PSDV <font color='green'>+4.9%</font>) marketing application seeking approval for Durasert for the three-year treatment of posterior segment uveitis &#40;PSA&#41;. The agency's action date is November 5.</li><li><a href=\"http://www.psivida.com/our-technology/#durasert\" target=\"_blank\">Durasert&nbsp;</a>is a miniaturized injectable sustained-release drug delivery system for small molecules (up to three years). The implant can be administered in an office setting via a needle as small as 25-gauge.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329300-psividas-durasert-shows-treatment-benefit-month-12-second-late-stage-psu-study-u-s-marketing\" target=\"_blank\">pSivida's Durasert shows treatment benefit at month 12 in second late-stage PSU study, U.S. marketing application submitted</a> (Feb. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340216\" data-linked=\"FDA accepts pSivida&#39;s marketing application for Durasert for PSU, action date November 5; shares ahead 5%\" data-tweet=\"$EYPT - FDA accepts pSivida&#39;s marketing application for Durasert for PSU, action date November 5; shares ahead 5% https://seekingalpha.com/news/3340216-fda-accepts-psividas-marketing-application-for-durasert-for-psu-action-date-november-5-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3340216-fda-accepts-psividas-marketing-application-for-durasert-for-psu-action-date-november-5-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340199\" data-ts=\"1521475305\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGOC\" target=\"_blank\">SGOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340199-consumer-top-gainers-losers-of-12-00-pm-3-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm (3/19/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SGOC' title='SGOCO Techn'>SGOC</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SEED' title='Origin Agritech Limited'>SEED</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/REED' title='Reed&#39;s, Inc.'>REED</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/VUZI' title='Vuzix Corp'>VUZI</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/NWL' title='Newell Brands Inc.'>NWL</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/IRBT' title='iRobot Corporation'>IRBT</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340199\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm (3/19/2018)\" data-tweet=\"$SGOC $SGOC $SEED - Consumer - Top Gainers / Losers as of 12:00 pm (3/19/2018) https://seekingalpha.com/news/3340199-consumer-top-gainers-losers-of-12-00-pm-3-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3340199-consumer-top-gainers-losers-of-12-00-pm-3-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340198\" data-ts=\"1521475258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHT\" target=\"_blank\">RHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340198-barclays-raises-red-hat-target-to-7-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barclays raises its Red Hat target to 7% upside</a></h4><ul><li>        Barclays raises its Red Hat (NYSE:<a href='https://seekingalpha.com/symbol/RHT' title='Red Hat, Inc.'>RHT</a>) price target by $20 to $165 (a 7% upside to Friday&rsquo;s close) ahead of next week&rsquo;s earnings.</li><li>               Firm says this quarter will have tough billings comps (Q4 last year featured 20% growth partly due to a deal slip), but the overall positive VAR survey results show long-term upside from the attractive hybrid cloud positioning and core and emerging product momentum.&nbsp;</li><li>               Source: Briefing.com.&nbsp;</li><li>               Red Hat will report Q4 results on March 26.&nbsp;</li><li>               Red Hat shares are&nbsp;<font color='red'>down 1%</font>&nbsp;to $152.69. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3340198\" data-linked=\"Barclays raises its Red Hat target to 7% upside\" data-tweet=\"$RHT - Barclays raises its Red Hat target to 7% upside https://seekingalpha.com/news/3340198-barclays-raises-red-hat-target-to-7-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3340198-barclays-raises-red-hat-target-to-7-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340195\" data-ts=\"1521475195\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RKDA\" target=\"_blank\">RKDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340195-arcadia-bio-secures-10m-private-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arcadia Bio secures $10M private capital raise</a></h4><ul><li>Arcadia Biosciences (<a href='https://seekingalpha.com/symbol/RKDA' title='Arcadia Biosciences'>RKDA</a> <font color='green'>+5.7%</font>) inks <a href=\"https://seekingalpha.com/pr/17105800-arcadia-biosciences-announces-10-million-private-placement\" target=\"_blank\">agreements </a>with institutional investors for the direct sale of $10M of common stock at $33.25 per share. Buyers will also receive five-year warrants with an exercise price of $45.75.</li><li>Friday's close was $41.91.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340195\" data-linked=\"Arcadia Bio secures $10M private capital raise\" data-tweet=\"$RKDA - Arcadia Bio secures $10M private capital raise https://seekingalpha.com/news/3340195-arcadia-bio-secures-10m-private-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3340195-arcadia-bio-secures-10m-private-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340190\" data-ts=\"1521474781\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRUB\" target=\"_blank\">GRUB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340190-grubhub-cut-to-hold-stifel-sharesminus-3_2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GrubHub cut to Hold by Stifel; shares -3.2%</a></h4><ul>   <li>GrubHub (NYSE:<a href='https://seekingalpha.com/symbol/GRUB' title='GrubHub Inc.'>GRUB</a>) shares are <font color='red'>down 3.2%</font> with today's news bringing an <a href=\"https://seekingalpha.com/news/3340100-wsj-grubhub-yelp-announcing-partnership-expansion-today\" target=\"_blank\">expansion</a> of the company's partnership with Yelp and a downgrade at Stifel Nicolaus to Hold.</li>    <li>Risk-reward is now balanced after <font color='green'>gains of more than 220%</font> over the past year, analyst John Egbert says in the ratings cut. An updated price target of $110 implies 2.8% upside.</li>    <li>The company's partnership with Yum Brands will mean <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/03/11381695/stifel-after-200-gain-in-one-year-grubhub-has-balanced-\" target=\"_blank\">\"material\" incremental revenue by 2019</a> (he lifted his estimate for the fiscal year by 2%, to $1.18B) and help press other high-profile chains to get on the platform, Egbert says.</li>    <li>But the stock price appreciation can't be ignored: Shares are at an \"elevated\" multiple of 31.5 time 2019 EV/EBITDA.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340190\" data-linked=\"GrubHub cut to Hold by Stifel; shares -3.2%\" data-tweet=\"$GRUB - GrubHub cut to Hold by Stifel; shares -3.2% https://seekingalpha.com/news/3340190-grubhub-cut-to-hold-stifel-sharesminus-3_2?source=tweet\" data-url=\"https://seekingalpha.com/news/3340190-grubhub-cut-to-hold-stifel-sharesminus-3_2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340178\" data-ts=\"1521472926\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBTC\" target=\"_blank\">GBTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340178-bitcoin-up-1000-fsb-says-crypto-not-pose-threat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitcoin up $1000; FSB says crypto does not pose a threat</a></h4><ul>     <li>Bitcoin rallied more than <a href=\"https://www.marketwatch.com/story/bitcoin-rallies-1000-after-fsb-letter-to-g-20-officials-2018-03-19\" target=\"_blank\">$1K on the news</a> of the Financial Stability Board <a href=\"http://www.fsb.org/wp-content/uploads/P180318.pdf\" target=\"_blank\">saying</a> cryptocurrencies do not pose a big threat to the financial system.</li>     <li>&ldquo;The FSB&rsquo;s initial assessment is that crypto-assets do not pose risks to global financial stability at this time,&rdquo; wrote the chairman of FSB, Mark Carney.</li>     <li>Bitcoin is above $8,600 after hitting a $7,400 low over the weekend.</li>     <li>Related tickers:&nbsp;<a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>, <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>, <a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>, <a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>, <a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a>, <a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a>, <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a>, <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a>, <a href='https://seekingalpha.com/symbol/BTLLF' title='Interbit Ltd.'>OTCPK:BTLLF</a> <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, <a href='https://seekingalpha.com/symbol/USTC' title='USA Real Estate Holding Co'>OTCPK:USTC</a>, <a href='https://seekingalpha.com/symbol/BLKCF' title='Global Blockchain Technologies Corp.'>OTCPK:BLKCF</a>, <a href='https://seekingalpha.com/symbol/COINB' title='Coinbase'>COINB</a>, <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3340178\" data-linked=\"Bitcoin up $1000; FSB says crypto does not pose a threat\" data-tweet=\"$GBTC $GBTC $COIN - Bitcoin up $1000; FSB says crypto does not pose a threat https://seekingalpha.com/news/3340178-bitcoin-up-1000-fsb-says-crypto-not-pose-threat?source=tweet\" data-url=\"https://seekingalpha.com/news/3340178-bitcoin-up-1000-fsb-says-crypto-not-pose-threat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340183\" data-ts=\"1521472807\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IIVI\" target=\"_blank\">IIVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340183-deutsche-bank-initiates-ii-vi-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank initiates II-VI at Buy</a></h4><ul><li>        Deutsche Bank initiates II-VI (NASDAQ:<a href='https://seekingalpha.com/symbol/IIVI' title='II-VI Incorporated'>IIVI</a>) at a Buy rating.</li><li>                  Price target: $56, a 26% upside to Friday&rsquo;s close. &nbsp;   </li><li>               Source: Briefing.com.&nbsp;</li><li>               II-VI shares are&nbsp;<font color='red'>down 1.1%</font>&nbsp;to $43.82. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3339777-optical-component-firms-finish-lower-b-riley-gets-cautious\" target=\"_blank\">Some optical component firms finish lower as B. Riley gets cautious</a> (March 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340183\" data-linked=\"Deutsche Bank initiates II-VI at Buy\" data-tweet=\"$IIVI - Deutsche Bank initiates II-VI at Buy https://seekingalpha.com/news/3340183-deutsche-bank-initiates-ii-vi-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3340183-deutsche-bank-initiates-ii-vi-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340182\" data-ts=\"1521472754\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340182-vale-nears-new-dividend-policy-after-deleveraging-selling-non-core-assets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vale nears new dividend policy after deleveraging, selling non-core assets</a></h4><ul>     <li>A new dividend policy to be announced by Vale (<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='red'>-3%</font>) should be <a href=\"https://www.ft.com/content/4370a99a-2279-11e8-9a70-08f715791301\" target=\"_blank\">based on a more sustainable cash flow generation</a> rather than profits or debt, CEO Fabio Schvartsman tells the <em>Financial Times</em> in an interview.</li>     <li>&ldquo;What you can distribute without hurting the company is the cash you generate,&rdquo; Schvartsman says.</li>     <li>Vale's net debt fell from more than $25B in 2016 to $18.1B in 2017, with at least another 3.7% reduction coming this year from the divestment of fertilizer assets and other deals, and of the company's 2018 debt goal, &ldquo;The target is $10B... the sooner we get there, the sooner we can start paying good dividends,&nbsp;Schvatsman tells <em>FT</em>.</li><li>At $10B of debt and an iron ore price this year of $67/metric ton, Vale&rsquo;s net debt to EBITDA ratio would be 0.6, in line with its competitors, says Credit Suisse analyst Ivano Westin, who expects the $10B target will be reached ahead of schedule.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340182\" data-linked=\"Vale nears new dividend policy after deleveraging, selling non-core assets\" data-tweet=\"$VALE - Vale nears new dividend policy after deleveraging, selling non-core assets https://seekingalpha.com/news/3340182-vale-nears-new-dividend-policy-after-deleveraging-selling-non-core-assets?source=tweet\" data-url=\"https://seekingalpha.com/news/3340182-vale-nears-new-dividend-policy-after-deleveraging-selling-non-core-assets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340179\" data-ts=\"1521472443\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APEI\" target=\"_blank\">APEI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340179-american-public-education-four-year-high-amid-workforce-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Public Education at four-year high amid workforce cuts</a></h4><ul>   <li>American Public Education (NASDAQ:<a href='https://seekingalpha.com/symbol/APEI' title='American Public Education, Inc.'>APEI</a>) is <font color='green'>up 3.8%</font> and tagged a new four-year high after weekend word that it committed to a workforce reduction plan.</li>    <li>Some 48 jobs will be affected, Bloomberg notes.</li>    <li>The reduction will be substantially complete by April 1.</li>    <li>Shares are <font color='green'>up 70.3%</font> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340179\" data-linked=\"American Public Education at four-year high amid workforce cuts\" data-tweet=\"$APEI - American Public Education at four-year high amid workforce cuts https://seekingalpha.com/news/3340179-american-public-education-four-year-high-amid-workforce-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/3340179-american-public-education-four-year-high-amid-workforce-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340177\" data-ts=\"1521472205\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATEN\" target=\"_blank\">ATEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340177-da-davidson-downgrades-a10-networks-on-late-filing-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DA Davidson downgrades A10 Networks on late filing concerns</a></h4><ul><li>        DA Davidson downgrades A10 Networks (NYSE:<a href='https://seekingalpha.com/symbol/ATEN' title='A10 Networks, Inc.'>ATEN</a>) from Buy to Neutral.</li><li>               Firm seeks further clarity on accounting issues after the company announced a delayed 10-K filing.&nbsp;</li><li>               DA Davidson notes that in similar situations a company that slips past the 15-day extension often takes substantial time to finalize.&nbsp;</li><li>                  Price target lowered by a dollar to $7, a 7% upside to Friday&rsquo;s close.    </li><li>               Source: Briefing.com.&nbsp;</li><li>               A10 shares are<font color='red'> down 8%</font>&nbsp;to $6.01.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3340177\" data-linked=\"DA Davidson downgrades A10 Networks on late filing concerns\" data-tweet=\"$ATEN - DA Davidson downgrades A10 Networks on late filing concerns https://seekingalpha.com/news/3340177-da-davidson-downgrades-a10-networks-on-late-filing-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3340177-da-davidson-downgrades-a10-networks-on-late-filing-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340173\" data-ts=\"1521471543\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340173-morgan-stanley-resumes-qualcomm-9-downside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley resumes Qualcomm at 9% downside</a></h4><ul><li>        Morgan Stanley <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Morgan+Stanley+Resumes+Qualcomm+%28QCOM%29+at+Underweight/13956806.html\" target=\"_blank\">resumes</a> coverage on Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) with an Underweight rating.</li><li>                  Price target: $55, a 9% downside to Friday&rsquo;s close.    </li><li>                  Qualcomm shares are&nbsp;<font color='red'>down 2.5%</font>&nbsp;to $59.10.&nbsp;&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3340046-jacobs-clear-merits-taking-qualcomm-private-amid-challenges\" target=\"_blank\">Jacobs: 'Clear merits' in taking Qualcomm private amid challenges</a> (March 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340173\" data-linked=\"Morgan Stanley resumes Qualcomm at 9% downside\" data-tweet=\"$QCOM - Morgan Stanley resumes Qualcomm at 9% downside https://seekingalpha.com/news/3340173-morgan-stanley-resumes-qualcomm-9-downside?source=tweet\" data-url=\"https://seekingalpha.com/news/3340173-morgan-stanley-resumes-qualcomm-9-downside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>65&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340169\" data-ts=\"1521471123\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NXPI\" target=\"_blank\">NXPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340169-morgan-stanley-resumes-nxp-semiconductors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley resumes NXP Semiconductors</a></h4><ul><li>        Morgan Stanley resumes NXP Semiconductors (NASDAQ:<a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a>) at an Equal Weight rating.</li><li>               Source: Briefing.com.&nbsp;</li><li>               Latest analyst <a href=\"https://markets.ft.com/data/equities/tearsheet/forecasts?s=NXPI:NSQ\" target=\"_blank\">recommendations</a>: 1 Buy, 13 Hold, and 1 Underperform.&nbsp;</li><li>               Median price target: $119. &nbsp;&nbsp;</li><li>               NXP shares are&nbsp;<font color='red'>down 0.2%</font>&nbsp;to $121.96.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3340169\" data-linked=\"Morgan Stanley resumes NXP Semiconductors\" data-tweet=\"$NXPI - Morgan Stanley resumes NXP Semiconductors https://seekingalpha.com/news/3340169-morgan-stanley-resumes-nxp-semiconductors?source=tweet\" data-url=\"https://seekingalpha.com/news/3340169-morgan-stanley-resumes-nxp-semiconductors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340167\" data-ts=\"1521470655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSCT\" target=\"_blank\">FSCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340167-forescoutminus-10_6-on-common-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ForeScout -10.6% on common stock offering</a></h4><ul><li>        ForeScout Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/FSCT' title='ForeScout Technologies, Inc.'>FSCT</a>) <a href=\"https://seekingalpha.com/filing/3941960\" target=\"_blank\">offers 500K shares</a> of common stock while selling stockholders offer 3.911K shares. Pricing not disclosed.</li><li>               Company will use the net proceeds, which only come from its share sale, for certain tax withholding obligations and to facilitate an orderly distribution of shares for selling stockholders.&nbsp;</li><li>               ForeScout shares are&nbsp;<font color='red'>down 10.6%</font>&nbsp;to $30.83.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3340167\" data-linked=\"ForeScout -10.6% on common stock offering\" data-tweet=\"$FSCT - ForeScout -10.6% on common stock offering https://seekingalpha.com/news/3340167-forescoutminus-10_6-on-common-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3340167-forescoutminus-10_6-on-common-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340165\" data-ts=\"1521470452\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLMT\" target=\"_blank\">CLMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340165-calumet-specialty-products-expects-revisions-to-q4-fy-2017-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Calumet Specialty Products expects revisions to Q4, FY 2017 results</a></h4><ul>     <li>Calumet Specialty Products Partners (<a href='https://seekingalpha.com/symbol/CLMT' title='Calumet Specialty Products Partners, L.P.'>CLMT</a> <font color='red'>-5.8%</font>) is lower after saying it <a href=\"https://seekingalpha.com/pr/17105391-calumet-specialty-products-partners-l-p-expects-revisions-previously-announced-2017-fourth\" target=\"_blank\">expects Q4 2017 results will differ</a> from the results presented in its recent earnings release.</li>     <li>While the company \"does not anticipate that the previously reported revenues and liquidity for the quarter will change materially, it does expect a decrease in its previously reported net income and adjusted EBITDA for [Q4] with a commensurate decrease in those line items for the full year 2017,\" CLMT says.</li><li>CLMT cites \"the ongoing implementation and associated learning process related to our new enterprise resource planning system\" for the revisions.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340165\" data-linked=\"Calumet Specialty Products expects revisions to Q4, FY 2017 results\" data-tweet=\"$CLMT - Calumet Specialty Products expects revisions to Q4, FY 2017 results https://seekingalpha.com/news/3340165-calumet-specialty-products-expects-revisions-to-q4-fy-2017-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3340165-calumet-specialty-products-expects-revisions-to-q4-fy-2017-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340164\" data-ts=\"1521470059\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340164-nomura-instinet-lowers-fy18-iphone-forecast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nomura Instinet lowers FY18 iPhone forecast</a></h4><ul><li>        Nomura Instinet <a href=\"https://www.cnbc.com/2018/03/19/analyst-sees-signs-of-trouble-due-to-apples-high-iphone-prices.html\" target=\"_blank\">reaffirms</a> its Neutral rating on Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) and drops its FY18 iPhone unit sales forecast from 226M to 221M (consensus: 224M).</li><li>               Analyst Jeffrey Kvaal says demand checks &ldquo;suggest little improvement in iPhone demand in 2018&rdquo; and supply chain &ldquo;downticks suggest iPhone expectations have yet to bottom.&rdquo;&nbsp;</li><li>               Kvaal says AT&amp;T&rsquo;s BOGO iPhone X promo didn&rsquo;t do well and was retracted after two weeks.&nbsp;</li><li>               But Apple isn&rsquo;t the only smartphone brand hurting. The analyst says preorders for Samsung&rsquo;s (<a href='https://seekingalpha.com/symbol/SSNNF' title='Samsung Electronics Co., Ltd.'>OTC:SSNNF</a>, <a href='https://seekingalpha.com/symbol/SSNLF' title='Samsung Electronics Co., Ltd.'>OTC:SSNLF</a>) Galaxy S9 are down 30%.&nbsp;</li><li>               Price target: $175, a 2% downside to Friday&rsquo;s close.&nbsp;</li><li>               Apple shares are&nbsp;<font color='red'>down 0.9%</font>&nbsp;to $176.38.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3340164\" data-linked=\"Nomura Instinet lowers FY18 iPhone forecast\" data-tweet=\"$AAPL $AAPL $SSNNF - Nomura Instinet lowers FY18 iPhone forecast https://seekingalpha.com/news/3340164-nomura-instinet-lowers-fy18-iphone-forecast?source=tweet\" data-url=\"https://seekingalpha.com/news/3340164-nomura-instinet-lowers-fy18-iphone-forecast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>58&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340162\" data-ts=\"1521469962\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDTX\" target=\"_blank\">CDTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340162-cidara-down-20-on-positive-mid-stage-data-on-rezafungin-acetate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cidara down 20% on &quot;positive&quot; mid-stage data on rezafungin acetate</a></h4><ul><li>Thinly traded Cidara Therapeutics (<a href='https://seekingalpha.com/symbol/CDTX' title='Cidara Therapeutics'>CDTX</a> <font color='red'>-19.6%</font>) is down on over a 6x surge in volume following its <a href=\"https://seekingalpha.com/pr/17105183-cidara-therapeutics-reports-positive-topline-results-phase-2-strive-trial-lead-antifungal\" target=\"_blank\">release </a>of Phase 2 data on lead antifungal candidate rezafungin acetate in patients with systemic <em>Candida </em>infection.</li><li>Shares initially spiked ~<font color='green'>20%</font>&nbsp;premarket based on the company's statement that the study met all of its objectives, but then quickly reversed after investors apparently looked closely at the results.</li><li>Two points stand out: the comparative data against caspofungin (Merck's <a href=\"http://www.empr.com/cancidas/drug/1845/\" target=\"_blank\">Cancidas</a>) were not statistically valid since STRIVE was not powered to demonstrate superiority or non-inferiority and the incidence of treatment-emergent adverse events was higher (88.6% and 94.4% for rezafungin versus 81.8% for caspofungin). The rates of severe adverse events, though, were lower in the rezafungin groups (37.1% and 27.8% vs. 39.4%).</li><li>The company plans to advance rezafungin into Phase 3 development.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3340107-cidaras-lead-drug-successful-mid-stage-study\" target=\"_blank\">Cidara's lead drug successful in mid-stage study</a> (March 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340162\" data-linked=\"Cidara down 20% on &quot;positive&quot; mid-stage data on rezafungin acetate\" data-tweet=\"$CDTX - Cidara down 20% on &quot;positive&quot; mid-stage data on rezafungin acetate https://seekingalpha.com/news/3340162-cidara-down-20-on-positive-mid-stage-data-on-rezafungin-acetate?source=tweet\" data-url=\"https://seekingalpha.com/news/3340162-cidara-down-20-on-positive-mid-stage-data-on-rezafungin-acetate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340160\" data-ts=\"1521469306\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPHI\" target=\"_blank\">IPHI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340160-inphiminus-6_1-on-analyst-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inphi -6.1% on analyst downgrade</a></h4><ul><li>        Northland Capital downgrades Inphi (NYSE:<a href='https://seekingalpha.com/symbol/IPHI' title='Inphi Corporation'>IPHI</a>) from Market Perform to Underperform.</li><li>               Source: Briefing.com.&nbsp;</li><li>                  Latest analyst <a href=\"https://markets.ft.com/data/equities/tearsheet/forecasts?s=IPHI:NYQ\" target=\"_blank\">recommendations</a>: 4 Buy, 4 Outperform, 4 Hold, and 1 Underperform.    </li><li>               Median price target: $35. &nbsp;&nbsp;</li><li>               Inphi shares are&nbsp;<font color='red'>down 6.1%</font>&nbsp;to $31.25.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3340160\" data-linked=\"Inphi -6.1% on analyst downgrade\" data-tweet=\"$IPHI - Inphi -6.1% on analyst downgrade https://seekingalpha.com/news/3340160-inphiminus-6_1-on-analyst-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3340160-inphiminus-6_1-on-analyst-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340157\" data-ts=\"1521469069\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCS\" target=\"_blank\">BCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340157-activist-investor-buys-5-stake-in-barclays\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Activist investor buys 5% stake in Barclays</a></h4><ul><li>Barclays (NYSE:<a href='https://seekingalpha.com/symbol/BCS' title='Barclays PLC'>BCS</a>) shares are&nbsp;<font color='green'>up&nbsp;5.7%</font>&nbsp;as the bank disclosed that activist investor Sherbourne has bought&nbsp;<a href=\"https://www.cnbc.com/2018/03/19/activist-investor-sherborn-buys-5-percent-of-barclays.html\" target=\"_blank\">a 5.2% stake</a>.</li><li>Sherborne is known as an investment fund focused on the \"turnaround\" business, and is well regarded by the market.</li><li>CEO Jes Staley has been in under pressure to make the British lender profitable again.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340157\" data-linked=\"Activist investor buys 5% stake in Barclays\" data-tweet=\"$BCS - Activist investor buys 5% stake in Barclays https://seekingalpha.com/news/3340157-activist-investor-buys-5-stake-in-barclays?source=tweet\" data-url=\"https://seekingalpha.com/news/3340157-activist-investor-buys-5-stake-in-barclays\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340158\" data-ts=\"1521468771\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KTOS\" target=\"_blank\">KTOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340158-canaccord-genuity-defends-kratos-62-upside-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canaccord Genuity defends Kratos with 62% upside target</a></h4><ul><li>        Canaccord Genuity defends Kratos Defense &amp; Security Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/KTOS' title='Kratos Defense & Security Solutions, Inc.'>KTOS</a>) after shares dropped 11% on Friday following a short report from Spruce Point Capital Management.</li><li>               While Canaccord felt the short report reflected several issues relevant to Kratos, the criticism largely focused on older data with &ldquo;little incremental information.&rdquo;&nbsp;</li><li>               Canaccord prefers to focus on more recent events and potential future upsides. The firm thinks Kratos has become a &ldquo;show me&rdquo; stock with a rich valuation that will become justified by increased Department of Defense investments that will expand margin and FCF improvements. &nbsp;&nbsp;</li><li>               Price target: $15, a 62% upside to Friday&rsquo;s close.&nbsp;</li><li>               Source: Briefing.com. &nbsp;&nbsp;</li><li>               Kratos shares are&nbsp;<font color='green'>up 3%</font>&nbsp;to $9.26.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3339938-kratos-defense-sinks-following-critical-spruce-point-analysis\" target=\"_blank\">Kratos Defense sinks following critical Spruce Point analysis</a> (March 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340158\" data-linked=\"Canaccord Genuity defends Kratos with 62% upside target\" data-tweet=\"$KTOS - Canaccord Genuity defends Kratos with 62% upside target https://seekingalpha.com/news/3340158-canaccord-genuity-defends-kratos-62-upside-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3340158-canaccord-genuity-defends-kratos-62-upside-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340156\" data-ts=\"1521468723\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSIQ\" target=\"_blank\">CSIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340156-canadian-solar-jumps-after-beating-q4-earnings-shipment-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canadian Solar jumps after beating Q4 earnings, shipment guidance</a></h4><ul>     <li>Canadian Solar (<a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a> <font color='green'>+6.6%</font>) surges after <a href=\"https://seekingalpha.com/news/3340082-canadian-solar-beats-0_05-misses-revenue\" target=\"_blank\">Q4 earnings</a> top expectations, revenues rise 66% Y/Y and solar shipments exceed company guidance.</li>     <li>CSIQ says Q4 solar module shipments totaled 1.83 GW, slightly lower than 1.87 GW in Q3 but beating guidance of 1.72-1.82 GW, and gross margin was 19.7%, compared to 17.5% in Q3 and Q4 guidance of 16.5%-18.5%.</li>     <li>CSIQ issues upside guidance for Q1, seeing revenues of $1.37B-$1.4B vs. $1.22B analyst consensus estimate, and expects total solar module shipments of 1.3-1.35 GW, including 65 MW for its own utility-scale solar power projects; it foresees Q1 gross margin of 10%-12%, which reflects the impact of lower margin U.S. solar projects already sold in the quarter.</li>     <li>For the full year, CSIQ sees revenues of $4.4B-$4.6B vs. $3.98B consensus, and expects total module shipments of 6.6-7.1 GW.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340156\" data-linked=\"Canadian Solar jumps after beating Q4 earnings, shipment guidance\" data-tweet=\"$CSIQ - Canadian Solar jumps after beating Q4 earnings, shipment guidance https://seekingalpha.com/news/3340156-canadian-solar-jumps-after-beating-q4-earnings-shipment-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3340156-canadian-solar-jumps-after-beating-q4-earnings-shipment-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340155\" data-ts=\"1521468583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFEC\" target=\"_blank\">NFEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340155-new-contracts-seen-boosting-nf-energy-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New contracts seen boosting NF Energy results</a></h4><ul><li>NF Energy (<a href='https://seekingalpha.com/symbol/NFEC' title='NF Energy Saving Corp.'>NFEC</a> <font color='green'>+217%</font>) skyrockets in early trade after <a href=\"https://seekingalpha.com/pr/17105565-nf-energy-saving-corporation-announces-new-contracts-signed-nf-energy\" target=\"_blank\">announcing</a> two recently signed sales contracts for valves that have an aggregate value of $2.5M.</li><li>Due to the amount, the company expects the contracts to have a positive impact on its operating results this year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340155\" data-linked=\"New contracts seen boosting NF Energy results\" data-tweet=\"$NFEC $BIMI - New contracts seen boosting NF Energy results https://seekingalpha.com/news/3340155-new-contracts-seen-boosting-nf-energy-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3340155-new-contracts-seen-boosting-nf-energy-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340153\" data-ts=\"1521467889\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340153-intel-elects-new-board-member-recommends-chairmans-extension\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel elects new board member, recommends chairman&#39;s extension</a></h4><ul><li>        Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) <a href=\"https://seekingalpha.com/pr/17105493-intel-board-directors-elects-new-director-extends-andy-bryant-s-term-intel-chairman-2019\" target=\"_blank\">elects</a> former Robert Wood Johnson foundation CEO Risa Lavizzo-Mourey to the board of directors.</li><li>               Lavizzo-Mourey becomes the fifth new independent director who has joined the board since early 2016.&nbsp;</li><li>                  Board also unanimously voted to extend Andy Bryant&rsquo;s term as chairman, which began in 2012. The re-election still has to go up for a shareholder vote at the annual meeting.   </li><li>               Intel shares are&nbsp;<font color='red'>down 0.4%</font>&nbsp;to $50.98.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3340153\" data-linked=\"Intel elects new board member, recommends chairman&#39;s extension\" data-tweet=\"$INTC - Intel elects new board member, recommends chairman&#39;s extension https://seekingalpha.com/news/3340153-intel-elects-new-board-member-recommends-chairmans-extension?source=tweet\" data-url=\"https://seekingalpha.com/news/3340153-intel-elects-new-board-member-recommends-chairmans-extension\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340151\" data-ts=\"1521467323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XTNT\" target=\"_blank\">XTNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340151-fda-clears-xtant-medicals-spinal-screw-system-shares-ahead-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA clears Xtant Medical&#39;s spinal screw system; shares ahead 11%</a></h4><ul><li>The FDA <a href=\"https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K180153\" target=\"_blank\">grants 510(k) clearance</a> for Xtant Medical's (<a href='https://seekingalpha.com/symbol/XTNT' title='Xtant Medical Holdings, Inc.'>XTNT</a> <font color='green'>+11.2%</font>) X-Spine Cortical Bone Screw System, used to immobilize and stabilize spinal segments as an adjunct to fusion.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340151\" data-linked=\"FDA clears Xtant Medical&#39;s spinal screw system; shares ahead 11%\" data-tweet=\"$XTNT - FDA clears Xtant Medical&#39;s spinal screw system; shares ahead 11% https://seekingalpha.com/news/3340151-fda-clears-xtant-medicals-spinal-screw-system-shares-ahead-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3340151-fda-clears-xtant-medicals-spinal-screw-system-shares-ahead-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340150\" data-ts=\"1521467080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340150-amazon-launches-cloud-based-gaming-service\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon launches cloud-based gaming service</a></h4><ul><li>           Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) <a href=\"https://www.cnbc.com/2018/03/19/amazon-launches-gameon-service-for-game-developers.html\" target=\"_blank\">introduces</a> the GameOn cloud service that helps developers easily add leaderboards, competitions, invites, and giveaways into games. </li><li> GameOn developers can also choose from certain products on Amazon&rsquo;s e-commerce platform to offer as a prize. </li><li> GameOn uses the AWS cloud platform but like Alexa and Dash doesn&rsquo;t fall under the AWS umbrella in a reporting sense. </li><li>           Last week, Microsoft announced a new cloud gaming division. The company previously acquired PlayFab, a cloud-based gaming service that helps developers integrate tournaments and leaderboards. &nbsp; </li><li>Amazon shares are&nbsp;<font color='red'>down 1.1%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3339582-microsoft-launches-cloud-gaming-division-offers-250k-cpu-bug-bounty\" target=\"_blank\">Microsoft launches cloud gaming division, offers $250K CPU bug bounty</a> (March 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340150\" data-linked=\"Amazon launches cloud-based gaming service\" data-tweet=\"$AMZN - Amazon launches cloud-based gaming service https://seekingalpha.com/news/3340150-amazon-launches-cloud-based-gaming-service?source=tweet\" data-url=\"https://seekingalpha.com/news/3340150-amazon-launches-cloud-based-gaming-service\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340148\" data-ts=\"1521466792\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRTX\" target=\"_blank\">HRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340148-herons-anesthetic-candidate-htxminus-011-successful-in-late-stage-studies-shares-up-40\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heron&#39;s anesthetic candidate HTX-011 successful in late-stage studies; shares up 40%</a></h4><ul><li>Heron Therapeutics (<a href='https://seekingalpha.com/symbol/HRTX' title='Heron Therapeutics, Inc.'>HRTX</a> <font color='green'>+39.8%</font>) jumps out the gate on the heels of its <a href=\"https://seekingalpha.com/pr/17105264-heron-announces-positive-topline-results-pivotal-phase-3-clinical-trials-htxminus-011\" target=\"_blank\">announcement </a>of positive results from two Phase 3 clinical trials assessing long-acting local anesthetic HTX-011 in patients undergoing bunionectomy (Study 301/EPOCH1) and hernia repair (Study 301/EPOCH1).</li><li>Both studies met all primary and secondary endpoints demonstrating statistically significant reductions in both pain intensity and the use of opioid rescue medications through 72 hours post surgery. HTX-011 was well-tolerated with a safety profile comparable to placebo and bupivacaine solution.</li><li>The company plans to file a U.S. marketing application in H2.</li><li>Fast Track-tagged <a href=\"http://www.herontx.com/HTX-011\" target=\"_blank\">HTX-011</a>&nbsp;is an injectable formulation based on the company's&nbsp;<a href=\"http://www.herontx.com/our-technologies\" target=\"_blank\">Bichronomer&nbsp;polymer-based drug delivery platform</a>&nbsp;which enables the release of bupivacaine and meloxicam over an extended period.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340148\" data-linked=\"Heron&#39;s anesthetic candidate HTX-011 successful in late-stage studies; shares up 40%\" data-tweet=\"$HRTX - Heron&#39;s anesthetic candidate HTX-011 successful in late-stage studies; shares up 40% https://seekingalpha.com/news/3340148-herons-anesthetic-candidate-htxminus-011-successful-in-late-stage-studies-shares-up-40?source=tweet\" data-url=\"https://seekingalpha.com/news/3340148-herons-anesthetic-candidate-htxminus-011-successful-in-late-stage-studies-shares-up-40\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340145\" data-ts=\"1521466143\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIT\" target=\"_blank\">FIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340145-fitbitplus-3_4-craig-hallum-starts-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fitbit +3.4% as Craig-Hallum starts at Buy</a></h4><ul>   <li>Fitbit (NYSE:<a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a>) is <font color='green'>up 3.4%</font> premarket after an initiation at Buy by Craig-Hallum.</li>    <li>The firm has set a generous price target of $10, implying 90% upside from Friday's close.</li>    <li>Shares are <font color='red'>down 12.5%</font> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340145\" data-linked=\"Fitbit +3.4% as Craig-Hallum starts at Buy\" data-tweet=\"$FIT - Fitbit +3.4% as Craig-Hallum starts at Buy https://seekingalpha.com/news/3340145-fitbitplus-3_4-craig-hallum-starts-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3340145-fitbitplus-3_4-craig-hallum-starts-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340144\" data-ts=\"1521466057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KLDX\" target=\"_blank\">KLDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340144-premarket-gainers-of-9-05-03-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (03/19/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/KLDX' title='Klondex Mines Ltd.'>KLDX</a> <font color='green'>+63%</font>&nbsp;on $462M <a href=\"https://seekingalpha.com/news/3340079-klondex-58-percent-premarket-462m-takeover-hecla-mining\" target=\"_blank\">takeover</a> by Hecla Mining (NYSE:<a href='https://seekingalpha.com/symbol/HL' title='Hecla Mining Co.'>HL</a>).</li>     <li><a href='https://seekingalpha.com/symbol/HRTX' title='Heron Therapeutics, Inc.'>HRTX</a> <font color='green'>+36%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17105264-heron-announces-positive-topline-results-pivotal-phase-3-clinical-trials-htxminus-011\" target=\"_blank\">positive</a> topline results from its completed Phase 3 studies of the investigational agent HTX-011 in subjects undergoing bunionectomy and hernia repair.</li>     <li><a href='https://seekingalpha.com/symbol/RKDA' title='Arcadia Biosciences'>RKDA</a> <font color='green'>+22%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17105250-arcadia-biosciences-launches-goodwheat-consumer-ingredient-brand\" target=\"_blank\">launch</a> of its GoodWheat consumer brand.</li>     <li><a href='https://seekingalpha.com/symbol/GERN' title='Geron Corporation'>GERN</a> <font color='green'>+15%&nbsp;</font>on rosier <a href=\"https://seekingalpha.com/news/3340102-geron-35-percent-premarket-rosier-outlook-imetelstat\" target=\"_blank\">outlook</a> for imetelstat.</li>     <li><a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color='green'>+15%</font>&nbsp;as FDA <a href=\"https://seekingalpha.com/news/3340017-fda-tags-cellectars-clr-131-orphan-drug-neuroblastoma-shares-9-percent-hours\" target=\"_blank\">tags</a> Cellectar's CLR 131 an Orphan Drug for neuroblastoma.</li>     <li><a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a> <font color='green'>+12%</font>&nbsp;on signing an&nbsp;agreement with Eni S.p.A.</li>     <li><a href='https://seekingalpha.com/symbol/ORBK' title='Orbotech Ltd.'>ORBK</a> <font color='green'>+10%</font>&nbsp;as KLA-Tencor (NASDAQ:<a href='https://seekingalpha.com/symbol/KLAC' title='KLA-Tencor Corporation'>KLAC</a>) <a href=\"https://seekingalpha.com/news/3340122-kla-tencor-acquires-orbotech-3_4b\" target=\"_blank\">acquires</a> Orbotech for $3.4B.</li>     <li><a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a> <font color='green'>+8%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3340084-cheetah-mobile-misses-rmb0_27-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/VIVE' title='Viveve Medical, Inc.'>VIVE</a> <font color='green'>+7%</font>&nbsp;as FDA <a href=\"https://seekingalpha.com/news/3340126-fda-signs-viveves-ide-new-indication-viveve-system-study-launch-next-quarter-shares-13\" target=\"_blank\">signs off</a> on Viveve's IDE for new indication for Viveve System, study to launch next quarter.</li>     <li><a href='https://seekingalpha.com/symbol/BCS' title='Barclays PLC'>BCS</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a> <font color='green'>+5%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3340082-canadian-solar-beats-0_05-misses-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a> <font color='green'>+6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340144\" data-linked=\"Premarket Gainers as of 9:05 am (03/19/2018)\" data-tweet=\"$KLDX $KLDX $HL - Premarket Gainers as of 9:05 am (03/19/2018) https://seekingalpha.com/news/3340144-premarket-gainers-of-9-05-03-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3340144-premarket-gainers-of-9-05-03-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340137\" data-ts=\"1521465404\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340137-goldman-reiterates-bearish-tesla-outlook-expects-q1-deliveries-to-disappoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman reiterates bearish Tesla outlook, expects Q1 deliveries to disappoint</a></h4><ul>     <li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) <font color='red'>-1.8%</font> premarket after Goldman Sachs <a href=\"https://www.marketwatch.com/story/tesla-shares-slide-16-premarket-after-goldman-reiterates-sell-rating-in-bearish-note-2018-03-19\" target=\"_blank\">reiterates its Sell rating</a> and $205 price target, saying data points so far suggest Q1 deliveries will prove disappointing.</li>     <li>\"We believe the company is tracking below its 2018 Model S/X guidance of approx. 100K units (an implied 25,000 per quarter),\" Goldman says. \"Further, while monthly Model 3 deliveries are showing sequential improvement, we estimate that they will fall well short of consensus expectations.\"</li><li>Goldman foresees a slow ramp for the Model 3 and expects TSLA shares to \"de-rate\" as targets are pushed out.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340137\" data-linked=\"Goldman reiterates bearish Tesla outlook, expects Q1 deliveries to disappoint\" data-tweet=\"$TSLA - Goldman reiterates bearish Tesla outlook, expects Q1 deliveries to disappoint https://seekingalpha.com/news/3340137-goldman-reiterates-bearish-tesla-outlook-expects-q1-deliveries-to-disappoint?source=tweet\" data-url=\"https://seekingalpha.com/news/3340137-goldman-reiterates-bearish-tesla-outlook-expects-q1-deliveries-to-disappoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>338&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340133\" data-ts=\"1521465309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BITA\" target=\"_blank\">BITA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340133-bitautoplus-1_8-sets-150m-buyback-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitauto +1.8% as it sets $150M buyback program</a></h4><ul>   <li>Bitauto (NYSE:<a href='https://seekingalpha.com/symbol/BITA' title='Bitauto Holdings Limited'>BITA</a>) is <font color='green'>up 1.8%</font> premarket after its board approves a <a href=\"https://seekingalpha.com/pr/17105348-bitauto-board-directors-approves-150-million-share-repurchase-program\" target=\"_blank\">$150M share repurchase program</a>.</li>    <li>The program covers the next 12 months and the company expects to fund buybacks from its cash balance.</li>    <li>\"The share purchase program announced today reflects our confidence in the long-term growth prospects of all of Bitauto's business lines,\" says CEO Andy Zhang. \"We will continue to activate synergies between Bitauto and Yixin, drive increased efficiencies in our media business, and realize economies of scale in Yixin.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340133\" data-linked=\"Bitauto +1.8% as it sets $150M buyback program\" data-tweet=\"$BITA - Bitauto +1.8% as it sets $150M buyback program https://seekingalpha.com/news/3340133-bitautoplus-1_8-sets-150m-buyback-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3340133-bitautoplus-1_8-sets-150m-buyback-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340132\" data-ts=\"1521465257\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MFGP\" target=\"_blank\">MFGP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340132-premarket-losers-of-9-05-3-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (3/19/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/MFGP' title='Micro Focus International plc ADR'>MFGP</a>&nbsp;<font color='red'>-52%</font>&nbsp;on&nbsp;CEO departure and <a href=\"https://seekingalpha.com/news/3340113-micro-focus-minus-54-percent-ceo-departure-lowered-guidance\" target=\"_blank\">lowered guidance</a>.</li><li><a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a> <font color='red'>-11%</font>.</li><li><a href='https://seekingalpha.com/symbol/CDTX' title='Cidara Therapeutics'>CDTX</a>&nbsp;<font color='red'>-11%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3340107-cidaras-lead-drug-successful-mid-stage-study\" target=\"_blank\">reporting</a> topline results from Phase 2 STRIVE trial of lead Antifungal Rezafungin.</li><li><a href='https://seekingalpha.com/symbol/HL' title='Hecla Mining Co.'>HL</a>&nbsp;<font color='red'>-9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3340079-klondex-58-percent-premarket-462m-takeover-hecla-mining\" target=\"_blank\">acquiring</a> three high-grade Nevada gold mines with the acquisition of Klondex Mines.</li><li><a href='https://seekingalpha.com/symbol/OLED' title='Universal Display Corporation'>OLED</a> <font color='red'>-7%</font>.</li><li><a href='https://seekingalpha.com/symbol/ZS' title='Zscaler'>ZS</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3340132\" data-linked=\"Premarket Losers as of 9:05 am (3/19/2018)\" data-tweet=\"$MFGP $MFGP $AMTX - Premarket Losers as of 9:05 am (3/19/2018) https://seekingalpha.com/news/3340132-premarket-losers-of-9-05-3-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3340132-premarket-losers-of-9-05-3-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340126\" data-ts=\"1521464546\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIVE\" target=\"_blank\">VIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340126-fda-signs-off-on-viveves-ide-for-new-indication-for-viveve-system-study-to-launch-next\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA signs off on Viveve&#39;s IDE for new indication for Viveve System, study to launch next quarter; shares up 13% premarket</a></h4><ul><li>Thinly traded micro cap Viveve Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/VIVE' title='Viveve Medical, Inc.'>VIVE</a>) is up&nbsp;<font color='green'>13%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17105357-viveve-announces-fda-approval-ide-conduct-viveve-ii-clinical-study\" target=\"_blank\">announcement </a>that the FDA has approved its Investigational Device Exemption &#40;IDE&#41; clearing the way for a clinical trial evaluating the <a href=\"http://www.viveve.com/geneveve-treatment/\" target=\"_blank\">Viveve System</a> for the improvement of sexual function in women following vaginal childbirth.</li><li>The 250-subject study will launch in Q2.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3326818-viveve-medicals-cmrf-shows-positive-effect-stress-urinary-incontinence-study\" target=\"_blank\">Viveve Medical's CMRF shows positive effect in stress urinary incontinence study</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340126\" data-linked=\"FDA signs off on Viveve&#39;s IDE for new indication for Viveve System, study to launch next quarter; shares up 13% premarket\" data-tweet=\"$VIVE - FDA signs off on Viveve&#39;s IDE for new indication for Viveve System, study to launch next quarter; shares up 13% premarket https://seekingalpha.com/news/3340126-fda-signs-off-on-viveves-ide-for-new-indication-for-viveve-system-study-to-launch-next?source=tweet\" data-url=\"https://seekingalpha.com/news/3340126-fda-signs-off-on-viveves-ide-for-new-indication-for-viveve-system-study-to-launch-next\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340118\" data-ts=\"1521464150\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNF\" target=\"_blank\">FNF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340118-fidelity-national-buys-stewart-information-for-1_2b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fidelity National buys Stewart Information for $1.2B</a></h4><ul><li>Fidelity National (NYSE:<a href='https://seekingalpha.com/symbol/FNF' title='Fidelity National Financial Inc.'>FNF</a>) will pay $50.20 per share to Stewart (NYSE:<a href='https://seekingalpha.com/symbol/STC' title='Stewart Information Services Corporation'>STC</a>) shareholders in cash and stock. The price is a 23% premium to Stewart's close on Friday.</li><li>Thomas G. Apel, Stewart's Chairman of Stewart said, &ldquo;Combining with Fidelity National Financial will create a strong portfolio of customers and business relationships, and will provide us with the ability to grow the Stewart brand.\"</li><li>Closing is expected by the first half of 2019, and requires Stewart stockholder approval.</li><li>Shares of both companies are up premarket, with <a href='https://seekingalpha.com/symbol/STC' title='Stewart Information Services Corporation'>STC</a>&nbsp;<font color='green'>up 12%</font>&nbsp;and <a href='https://seekingalpha.com/symbol/FNF' title='Fidelity National Financial Inc.'>FNF</a>&nbsp;<font color='green'>up 3%&nbsp;</font></li><li>Source: <a href=\"https://seekingalpha.com/pr/17105294-fidelity-national-financial-inc-announces-signing-merger-agreement-acquire-stewart\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3340118\" data-linked=\"Fidelity National buys Stewart Information for $1.2B\" data-tweet=\"$FNF $FNF $STC - Fidelity National buys Stewart Information for $1.2B https://seekingalpha.com/news/3340118-fidelity-national-buys-stewart-information-for-1_2b?source=tweet\" data-url=\"https://seekingalpha.com/news/3340118-fidelity-national-buys-stewart-information-for-1_2b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340122\" data-ts=\"1521464098\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KLAC\" target=\"_blank\">KLAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340122-kla-tencor-acquires-orbotech-for-3_4b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KLA-Tencor acquires Orbotech for $3.4B</a></h4><ul><li>        KLA-Tencor (NASDAQ:<a href='https://seekingalpha.com/symbol/KLAC' title='KLA-Tencor Corporation'>KLAC</a>) <a href=\"https://seekingalpha.com/pr/17105317-kla-tencor-announces-agreement-acquire-orbotech-ltd\" target=\"_blank\">will acquire</a> Orbotech (NASDAQ:<a href='https://seekingalpha.com/symbol/ORBK' title='Orbotech Ltd.'>ORBK</a>) for a total of about $69.02/share.</li><li>               Price includes $38.86 in cash and 0.25 of a KLAC share for each Orbotech share.&nbsp;</li><li>                  Transaction gives Orbotech an equity value of $3.4B and an enterprise value of $3.2B.    </li><li>               KLA-Tencor says the acquisition expands its TAM by $2.5 in high-growth electronics end markets and expects the deal to be immediately accretive to revenue growth, non-GAAP earnings, and FCF/share with approximately $50M run-rate synergies.&nbsp;</li><li>               KLA-Tencor also announces a $2B share repurchase authorization that&rsquo;s expected to complete within 12 to 18 months after the acquisition closes. Deal expected to close by the end of CY18.&nbsp;&nbsp;</li><li>               KLA-Tencor shares are&nbsp;<font color='red'>down 1.3%</font>&nbsp;premarket.&nbsp;&nbsp;</li><li>        Orbotech shares are&nbsp;<font color='green'>up 11.5%</font>.&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3340122\" data-linked=\"KLA-Tencor acquires Orbotech for $3.4B\" data-tweet=\"$KLAC $KLAC $ORBK - KLA-Tencor acquires Orbotech for $3.4B https://seekingalpha.com/news/3340122-kla-tencor-acquires-orbotech-for-3_4b?source=tweet\" data-url=\"https://seekingalpha.com/news/3340122-kla-tencor-acquires-orbotech-for-3_4b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340113\" data-ts=\"1521463152\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MFGP\" target=\"_blank\">MFGP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340113-micro-focusminus-54-on-ceo-departure-lowered-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micro Focus -54% on CEO departure, lowered guidance</a></h4><ul><li>        Micro Focus International (NYSE:<a href='https://seekingalpha.com/symbol/MFGP' title='Micro Focus International plc ADR'>MFGP</a>)&nbsp;<font color='red'>plunges 54%</font>&nbsp;premarket after <a href=\"https://www.reuters.com/article/microfocus-outlook/update-3-shares-in-britains-micro-focus-halve-after-sales-warning-and-ceo-departure-idUSL8N1R11H4\" target=\"_blank\">losing its CEO</a> and lowering its forecast.</li><li>               CEO Chris Hsu left to spend time with family after a little over a year at the job. COO Stephen Murdoch will step into the position.&nbsp;&nbsp;</li><li>               Micro Focus spent $8.8B last year to buy Hewlett Packard Enterprise&rsquo;s (NYSE:<a href='https://seekingalpha.com/symbol/HPE' title='Hewlett Packard Enterprise'>HPE</a>) software business and has experienced difficulties integrating the unit.&nbsp;</li><li>               Exec chairman Kevin Loosemore: &ldquo;We&rsquo;re finding the integration harder than wed&rsquo; anticipated or planned. (We have) no regrets at all (on the deal but) the returns clearly may be delayed slightly.&rdquo;</li><li>               Full year forecast now expects revenue to drop 6% to 9% (was: down 2% to 4%) with 1H down 9% to 12%.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321600-micro-focus-minus-17-percent-post-hpe-merger-interim-results\" target=\"_blank\">Micro Focus -17% after post-HPE merger interim results</a> (Jan. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340113\" data-linked=\"Micro Focus -54% on CEO departure, lowered guidance\" data-tweet=\"$MFGP $MFGP $HPE - Micro Focus -54% on CEO departure, lowered guidance https://seekingalpha.com/news/3340113-micro-focusminus-54-on-ceo-departure-lowered-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3340113-micro-focusminus-54-on-ceo-departure-lowered-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340111\" data-ts=\"1521462898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340111-grubhub-downgraded-stifel-on-valuation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GrubHub downgraded at Stifel on valuation</a></h4><ul>     <li>GrubHub <font color='red'>-2.1%</font> premarket after Stifel <a href=\"https://www.streetinsider.com/Analyst+Comments/Stifel+Downgrades+GrubHub+Inc.+%28GRUB%29+to+Hold+Citing+Valuation/13956721.html\" target=\"_blank\">downgrades</a> shares to Hold from Buy with a $110 price target, citing\\ valuation as near-term risk-reward appears balanced at current levels.</li>     <li>Stifel notes shares have performed exceptionally well in 2018, rising 54% YTD vs. just 3% for the S&amp;P 500, and the company has executed well over the past several quarters, particularly in its 1P delivery business, which the firm expects to benefit meaningfully from the partnership with Yum! Brands to begin later this year.</li><li><a href=\"https://seekingalpha.com/news/3340100-wsj-grubhub-yelp-announcing-partnership-expansion-today\" target=\"_blank\">Earlier</a>: GrubHub, Yelp announcing partnership expansion today (Mar. 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340111\" data-linked=\"GrubHub downgraded at Stifel on valuation\" data-tweet=\"GrubHub downgraded at Stifel on valuation https://seekingalpha.com/news/3340111-grubhub-downgraded-stifel-on-valuation?source=tweet\" data-url=\"https://seekingalpha.com/news/3340111-grubhub-downgraded-stifel-on-valuation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340109\" data-ts=\"1521462671\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSY\" target=\"_blank\">INSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340109-insys-reiterates-commitment-to-ethical-practices-after-indictment-of-five-docs-tied-to\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">INSYS reiterates commitment to ethical practices after indictment of five docs tied to the company</a></h4><ul><li>INSYS Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a>) is down&nbsp;<font color='red'>5%</font>&nbsp;premarket, albeit on only 8 shares, on the heels of its <a href=\"https://seekingalpha.com/pr/17105305-insys-therapeutics-reiterates-commitment-compliant-ethical-business-practices-advancing\" target=\"_blank\">statement </a>that it remains committed to ethical behavior and the resolution of past issues related to its promotion of pain med Subsys (fentanyl).</li><li>The company responded after the feds <a href=\"https://www.nytimes.com/2018/03/16/nyregion/fentanyl-subsys-drug-kickbacks.html\" target=\"_blank\">indicted </a>five New York physicians last week with ties to former employees.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340109\" data-linked=\"INSYS reiterates commitment to ethical practices after indictment of five docs tied to the company\" data-tweet=\"$INSY $INSYQ - INSYS reiterates commitment to ethical practices after indictment of five docs tied to the company https://seekingalpha.com/news/3340109-insys-reiterates-commitment-to-ethical-practices-after-indictment-of-five-docs-tied-to?source=tweet\" data-url=\"https://seekingalpha.com/news/3340109-insys-reiterates-commitment-to-ethical-practices-after-indictment-of-five-docs-tied-to\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340108\" data-ts=\"1521462363\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340108-facebookminus-3_33-on-cambridge-analytica-fallout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook -3.33% on Cambridge Analytica fallout</a></h4><ul><li>        Facebook (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a>) shares are pressed&nbsp;<font color='red'>down 3.3%&nbsp;</font>premarket on the first trading day since the social network <a href=\"https://www.wsj.com/articles/facebook-ignites-debate-over-third-party-access-to-user-data-1521414746\" target=\"_blank\">suspended Cambridge Analytic</a>a&nbsp;for user data violations.</li><li>               The firm had ties to the 2016 Trump campaign.&nbsp;</li><li>               Facebook execs argued that the matter didn&rsquo;t constitute a data breach but admitted that Cambridge abused data previously provided openly to third parties.&nbsp;</li><li>               That open data, called Facebook&rsquo;s &ldquo;social graph&rdquo;, included the friend lists, interest, and &ldquo;likes&rdquo; tying a user base together.&nbsp;</li><li>               Facebook stopped sharing social graphs in 2015. Information developers already had could still be passed on to third-party developers despite violating the new rules.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3340051-facebook-suspends-trump-affiliated-data-firm-draws-uk-probe-updated\" target=\"_blank\">Facebook suspends Trump-affiliated data firm, draws UK probe (updated)</a> (March 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340108\" data-linked=\"Facebook -3.33% on Cambridge Analytica fallout\" data-tweet=\"$FB - Facebook -3.33% on Cambridge Analytica fallout https://seekingalpha.com/news/3340108-facebookminus-3_33-on-cambridge-analytica-fallout?source=tweet\" data-url=\"https://seekingalpha.com/news/3340108-facebookminus-3_33-on-cambridge-analytica-fallout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>197&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340105\" data-ts=\"1521461453\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTNT\" target=\"_blank\">FTNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340105-keybanc-downgrades-fortinet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KeyBanc downgrades Fortinet</a></h4><ul><li>        KeyBanc <a href=\"https://www.streetinsider.com/Analyst+Comments/KeyBanc+Downgrades+Fortinet+%28FTNT%29+to+Sector+Weight/13956787.html\" target=\"_blank\">downgrades</a> Fortinet (NASDAQ:<a href='https://seekingalpha.com/symbol/FTNT' title='Fortinet, Inc.'>FTNT</a>) from Overweight to Sector Weight.</li><li>               Analyst Rob Owens cites recent strengths combined with concerns about future margin expansion.&nbsp;</li><li>               Fortinet shares are&nbsp;<font color='red'>down 2.1%</font>&nbsp;premarket to $52.89. &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3340105\" data-linked=\"KeyBanc downgrades Fortinet\" data-tweet=\"$FTNT - KeyBanc downgrades Fortinet https://seekingalpha.com/news/3340105-keybanc-downgrades-fortinet?source=tweet\" data-url=\"https://seekingalpha.com/news/3340105-keybanc-downgrades-fortinet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340102\" data-ts=\"1521461023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GERN\" target=\"_blank\">GERN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340102-geron-up-35-premarket-on-rosier-outlook-for-imetelstat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Geron up 35% premarket on rosier outlook for imetelstat</a></h4><ul><li>Geron (NASDAQ:<a href='https://seekingalpha.com/symbol/GERN' title='Geron Corporation'>GERN</a>) is up&nbsp;<font color='green'>35%</font>&nbsp;premarket on modest volume in apparent reaction to its <a href=\"https://seekingalpha.com/pr/17104812-geron-corporation-reports-fourth-quarter-annual-2017-financial-results-recent-events\" target=\"_blank\">update </a>on a mid-stage study assessing imetelstat in treatment-resistant patients with lower-risk myelodysplastic syndromes &#40;MDS&#41;. It reported the progress in the study, called IMerge, in its Q4 results announcement after the close on Friday, March 16.</li><li>IMerge involves red blood cell transfusion-dependent MDS patients who have not responded to treatment with an erythropoiesis stimulating agent. Last month, licensee Janssen Research &amp; Development (NYSE:<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a>) completed the enrollment of 20 additional patients in the expanded Part 1 of the trial from a subset of subjects who were responding to treatment with imetestat.</li><li>Another Phase 2, IMbark, in patients with intermediate-2 or high-risk myelofibrosis who have not responded to treatment with a JAK inhibitor, is ongoing. At month 19, median overall survival &#40;OS&#41;&nbsp;has not been reached in either dosing arm. Based on the rate of deaths in the study, the assessment of OS should begin by late Q2. An extension phase is being planned.</li><li>After the completion of the primary analysis of IMbark, Janssen will notify the company if it plans to continue development, expected by late Q3.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3283819-geron-13-percent-early-trading-extended-timeline-imetelstat-study-risk-janssen-will-bail\" target=\"_blank\">Geron down 13% in early trading on extended timeline for imetelstat study, risk that Janssen will bail</a> (Aug. 1, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340102\" data-linked=\"Geron up 35% premarket on rosier outlook for imetelstat\" data-tweet=\"$GERN $GERN $JNJ - Geron up 35% premarket on rosier outlook for imetelstat https://seekingalpha.com/news/3340102-geron-up-35-premarket-on-rosier-outlook-for-imetelstat?source=tweet\" data-url=\"https://seekingalpha.com/news/3340102-geron-up-35-premarket-on-rosier-outlook-for-imetelstat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340100\" data-ts=\"1521460811\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRUB\" target=\"_blank\">GRUB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340100-wsj-grubhub-yelp-announcing-partnership-expansion-today\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: Grubhub, Yelp announcing partnership expansion today</a></h4><ul><li>        <a href=\"https://www.wsj.com/articles/grubhub-expands-pact-with-yelp-aiming-for-cheaper-deliveries-1521451921?mod=rss_Technology\" target=\"_blank\">WSJ reports</a> that GrubHub (NYSE:<a href='https://seekingalpha.com/symbol/GRUB' title='GrubHub Inc.'>GRUB</a>) and Yelp (NYSE:<a href='https://seekingalpha.com/symbol/YELP' title='Yelp'>YELP</a>) will announce extended partnerships today that will double the number of included U.S. restaurants to 80K.</li><li>               The deal completes GrubHub&rsquo;s $288M acquisition of Yelp&rsquo;s Eat24 restaurant delivery directory.&nbsp;</li><li>               Yelp will get an undisclosed cut of each GrubHub order placed through its website and app.&nbsp;</li><li>               GrubHub CEO Matt Maloney says the increased scale will allow Grubhub to eventually cut delivery fees since drivers can make multiple deliveries in one trip.&nbsp;</li><li>               Maloney: &ldquo;I see a point where we could conceivably have extremely low if not free delivery for consumers.&rdquo;&nbsp;</li><li>               GrubHub shares are&nbsp;<font color='red'>down 2.1%</font>&nbsp;premarket.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329319-yum-brands-grubhub-announce-strategic-partnership\" target=\"_blank\">Yum Brands and Grubhub announce strategic partnership</a> (Feb. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3340100\" data-linked=\"WSJ: Grubhub, Yelp announcing partnership expansion today\" data-tweet=\"$GRUB $GRUB $YELP - WSJ: Grubhub, Yelp announcing partnership expansion today https://seekingalpha.com/news/3340100-wsj-grubhub-yelp-announcing-partnership-expansion-today?source=tweet\" data-url=\"https://seekingalpha.com/news/3340100-wsj-grubhub-yelp-announcing-partnership-expansion-today\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340093\" data-ts=\"1521458865\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REGN\" target=\"_blank\">REGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340093-regenerons-eylea-successful-in-late-stage-study-in-background-retinopathy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Regeneron&#39;s Eylea successful in late-stage study in background retinopathy</a></h4><ul><li>A Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02718326?titles=panorama&amp;spons=regeneron&amp;phase=2&amp;rank=1\" target=\"_blank\">PANORAMA</a>, assessing Regeneron Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a>) EYLEA (aflibercept) in patients with moderately severe-to-severe non-proliferative diabetic retinopathy&nbsp;<a href=\"https://seekingalpha.com/pr/17105172-eylea-aflibercept-injection-demonstrates-positive-topline-results-phase-3-non-proliferative\" target=\"_blank\">met the 24-week primary endpoint</a>.</li><li>Specifically, 58% of patients treated with EYLEA experienced at least a two-step improvement from baseline in a scale called DRSS compared to 6% in those receiving sham (placebo) injection (p&lt;0.0001).</li><li>The results will be submitted for presentation at a future medical conference and will also be the basis for a U.S. marketing application.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340093\" data-linked=\"Regeneron&#39;s Eylea successful in late-stage study in background retinopathy\" data-tweet=\"$REGN - Regeneron&#39;s Eylea successful in late-stage study in background retinopathy https://seekingalpha.com/news/3340093-regenerons-eylea-successful-in-late-stage-study-in-background-retinopathy?source=tweet\" data-url=\"https://seekingalpha.com/news/3340093-regenerons-eylea-successful-in-late-stage-study-in-background-retinopathy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340092\" data-ts=\"1521458103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NWL\" target=\"_blank\">NWL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340092-newell-reaches-deal-icahn-for-four-new-board-nominees\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Newell reaches deal with Icahn for four new board nominees</a></h4><ul>     <li>Newell Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/NWL' title='Newell Brands Inc.'>NWL</a>)&nbsp;<font color='green'>+4.7%</font> premarket after announcing a <a href=\"https://seekingalpha.com/pr/17105098-newell-brands-announces-agreement-carl-c-icahn\" target=\"_blank\">cooperation agreement with activist investor Carl Icahn</a> which includes four new independent directors on its board.</li>     <li>As part of the agreement, NWL says it will expand its transformation plan, aiming to raise $10B in proceeds from divestitures.</li>     <li>NWL also is in a <a href=\"https://seekingalpha.com/news/3329727-wsj-starboard-launch-proxy-fight-replace-entire-newell-brands-board\" target=\"_blank\">proxy battle</a> with Starboard Value, which is pushing to replace the company's entire board and its CEO.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3340092\" data-linked=\"Newell reaches deal with Icahn for four new board nominees\" data-tweet=\"$NWL - Newell reaches deal with Icahn for four new board nominees https://seekingalpha.com/news/3340092-newell-reaches-deal-icahn-for-four-new-board-nominees?source=tweet\" data-url=\"https://seekingalpha.com/news/3340092-newell-reaches-deal-icahn-for-four-new-board-nominees\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340083\" data-ts=\"1521457123\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FMI\" target=\"_blank\">FMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340083-medicare-to-cover-foundation-medicines-ngs-genomic-profiling-assay-across-all-solid-tumors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medicare to cover Foundation Medicine&#39;s NGS genomic profiling assay across all solid tumors</a></h4><ul><li>Foundation Medicine (NASDAQ:<a href='https://seekingalpha.com/symbol/FMI' title='Foundation Medicine, Inc.'>FMI</a>) <a href=\"https://seekingalpha.com/pr/17105001-foundation-medicine-announces-final-national-coverage-determination-ncd-centers-medicare-and\" target=\"_blank\">announces </a>that the U.S. Centers for Medicare &amp; Medicaid Services &#40;CMS&#41; has OK'd reimbursement for its<a href=\"https://www.foundationmedicine.com/genomic-testing/foundation-one-cdx\" target=\"_blank\"> FoundationOne CDx</a> comprehensive next-generation sequencing &#40;NGS&#41; genomic profiling assay for all solid tumors incorporating a broad range of companion diagnostics, the only test to meet the requirements for coverage.</li><li>CEO Troy Cox says, &ldquo;We applaud CMS for issuing this final National Coverage Determination that significantly expands coverage beyond the preliminary draft policy. Most notably, the NCD, as it applies to FoundationOne CDx, will provide coverage for eligible patients across all solid tumors. The final NCD will significantly improve access and coverage for Medicare beneficiaries to comprehensive genomic profiling and biomarker-driven treatments. We look forward to commercializing FoundationOne CDx by the end of March, providing the oncology community with the only FDA-approved broad assay for all solid tumors.&rdquo;</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340083\" data-linked=\"Medicare to cover Foundation Medicine&#39;s NGS genomic profiling assay across all solid tumors\" data-tweet=\"$FMI - Medicare to cover Foundation Medicine&#39;s NGS genomic profiling assay across all solid tumors https://seekingalpha.com/news/3340083-medicare-to-cover-foundation-medicines-ngs-genomic-profiling-assay-across-all-solid-tumors?source=tweet\" data-url=\"https://seekingalpha.com/news/3340083-medicare-to-cover-foundation-medicines-ngs-genomic-profiling-assay-across-all-solid-tumors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3340079\" data-ts=\"1521455433\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KLDX\" target=\"_blank\">KLDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3340079-klondex-up-58-premarket-on-462m-takeover-hecla-mining\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Klondex up 58% premarket on $462M takeover by Hecla Mining</a></h4><ul><li>Klondex Mines (NYSEMKT:<a href='https://seekingalpha.com/symbol/KLDX' title='Klondex Mines Ltd.'>KLDX</a>) is up&nbsp;<font color='green'>58%</font>&nbsp;premarket on light volume on the heels of the <a href=\"https://seekingalpha.com/pr/17105038-hecla-acquire-three-high-grade-nevada-gold-mines-acquisition-klondex-mines-ltd\" target=\"_blank\">news </a>that Hecla Mining Company (NYSE:<a href='https://seekingalpha.com/symbol/HL' title='Hecla Mining Co.'>HL</a>) will acquire all of its outstanding shares for $462M in cash ($2.47/share).</li><li>Hecla is down&nbsp;<font color='red'>5%</font>&nbsp;premarket, albeit on only 100 shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3340079\" data-linked=\"Klondex up 58% premarket on $462M takeover by Hecla Mining\" data-tweet=\"$KLDX $KLDX $HL - Klondex up 58% premarket on $462M takeover by Hecla Mining https://seekingalpha.com/news/3340079-klondex-up-58-premarket-on-462m-takeover-hecla-mining?source=tweet\" data-url=\"https://seekingalpha.com/news/3340079-klondex-up-58-premarket-on-462m-takeover-hecla-mining\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":72,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}